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Summary
Neurovascular coupling (NVC) is the process whereby the brain increases local blood
supply in response to neuronal activity, providing neurons with energy. Disruptions to
NVC have been implicated in Alzheimer’s disease (AD), so a better understanding of
how NVC goes wrong, and when, is imperative for better understanding the disease and
assisting in the identification of therapeutic targets. The main genetic risk factor for
developing AD, expression of Apolipoprotein ε4 (APOE4), is associated with vascular
deficits, including pericyte damage and impaired cerebral blood flow. I tested whether
expression of APOE4 affected NVC, by studying neuronal activity and vascular responses
in visual cortex.
To investigate this, mice with humanised APOE4 or APOE3 were crossed with mice
expressing a genetically-encoded calcium indicator or with labelled pericytes. Mice were
implanted with a cranial window over visual cortex and neuronal and vascular activity
was recorded using two-photon microscopy. Baseline and stimulus evoked measurements
were taken to determine the effect of ApoE4 on basal energy balance and on the ability
of the brain to deliver adequate energy to neurons.
Results suggest that there were some baseline alterations in APOE4 mice that may result
in a lower energy supply. Compounding this,I found there to be a mismatch in energy
supply and demand during sensory stimulation, where neuronal demand was greater, but
blood supply was less reliable in APOE4 mice.
Together these data suggest that there could be an energy deficit in APOE4 carriers. In
vivo studies investigating the role of ApoE4 in NVC are few and the study of individual
vessels and neurons across different age points, as done in this body of work, is a novel and
unique approach. By better understanding how ApoE4 modulates neurovascular function,
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Disruptions to the neurovasculature have been implicated in a number of conditions, in-
cluding Alzheimer’s Disease (AD), yet the details of how and when these may occur are
poorly understood. Carriers of the ε4 allele of the Apolipoprotein E gene, are at an in-
creased risk of developing AD, and evidence shows there to be a myriad of deleterious
interactions between ApoE4 and the vasculature early in the disease process (Zlokovic,
2013). Therefore, a better understanding of how ApoE4 might modulate vascular func-
tion is imperative for furthering our understanding of its role in AD pathophysiology and
thus aid in the identification of potential therapeutic targets.
One of the key functions of the neurovasculature is to increase local blood supply, and
therefore energy delivery, in response to neuronal activity, a process called neurovascu-
lar coupling (NVC). In this chapter I will discuss the importance of NVC in the healthy
brain, how neurons communicate with the vasculature to induce dilatations and how the
dilations are conducted along the vasculature.
There is plentiful evidence to suggest that there is vascular dysfunction in AD and that
it may be one of the earliest features of the disease, indeed many of the risk factors for
developing AD have a vascular component and also increase the risk of developing cardi-
ovascular diseases (Livingston et al., 2017). I will discuss, in brief, the main characteristics
of AD, alongside evidence that shows vascular dysfunction to be a key player in the dis-
ease process. This includes disruption to the vascular anatomy, cerebral blood flow, altered
neurovascular coupling and interactions between the vasculature and the two pathological
hallmarks of AD - amyloid beta and hyperphosphorylated tau.
As vascular dysfunction is thought to first occur early in the disease trajectory, prior to the
accumulation of amyloid beta and hyperphosphorylated tau (Iturria-Medina et al., 2016),
it is essential that we understand how deficits occurs in the absence of these proteins and
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how they might facilitate disease progression. The biggest greatest risk for going on to
develop AD is the APOE4 gene, and evidence shows that disruption to vascular function
is an early feature of ApoE4 pathophysiology (Zlokovic, 2013). I will discuss the physiolo-
gical role of APOE in the healthy brain before exploring the existing evidence showing
the role of ApoE4 in AD and, importantly, how it interacts with the neurovasculature in
a manner that is independent from amyloid beta and hyperphosphorylated tau. I suggest
that over time, these interactions could lead to an energy imbalance in the brain as a result
of inadequate blood supply, leading to neuronal ill-health and eventually the accumulation
of amyloid beta and hyper-phosphorylated tau.
This body of evidence supports the “Two Hit Hypothesis of Alzheimer’s Disease” proposed
by Berislav Zlokovic (Zlokovic, 2011). In this hypothesis he suggests that AD consists of
two “hits” that converge. “Hit” one is vascular dysfunction as a result of a risk factor
such as ApoE4. The downstream effects of this vascular dysfunction facilitate “hit” two,
the production of amyloid beta and pathological tau, eventually leading to the neurode-
generation and cognitive decline observed in AD.
It is the hope that the presentation of this existing evidence demonstrates that, in agree-
ment with the two hit hypothesis, investigation into the effect of ApoE4 on the neur-
ovasculature and the functional hyperaemia response, as is carried out in this thesis, is a
valuable and important research avenue.
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1.1 Neurovascular Coupling
The brain has a limited ability to store energy in the form of oxygen and glucose and so
relies upon the delivery of these substrates via the blood, a process termed neurovascu-
lar coupling (NVC). In fact, the brain is so energetically demanding, it constitutes only
2% of the body’s mass but utilises 20% of its available energy at rest (Attwell et al.,
2010; Attwell and Laughlin, 2001). The majority of this energy consumption (50%) is at
postsynaptic glutamate receptors, where it is used for the reversal of ions against their
electrochemical gradients, with 21% of signalling energy being used on action potentials
and 20% on resting potentials (Howarth et al., 2012). This phenomenon of neurovascular
coupling was first described in the late 1800’s in humans by Mosso (1880) and in animals
by Roy and Sherrington (1890). Despite a paucity of interest in the field in the following
decades, NVC is now a process that is widely researched and is accepted as one of the
brain’s many fundamental and critical functions.
This demand for a constant energy supply in response to neuronal activity within the
brain, has resulted in a dense network of cerebral vasculature. In neocortex, this network
is composed of anatomically heterogeneous blood vessels (see figure 1.2), with large pial
arterioles, enwrapped in several layers of smooth muscle cells (SMCs), that are present
across the surface of the brain before they dive into the tissue and transition into pen-
etrating arterioles. Penetrating arterioles are encased in astrocytic endfeet, as well as a
thinner layer of SMCs. As the SMCs thin to a single layer and the arterioles branch to
form a dense capillary network, SMCs are replaced with pericytes, encased within the
basement membrane and also enwrapped in astrocytic endfeet. Blood is then drained
from the capillaries by venules which transition to ascending veins and then large pial
veins (Kisler et al., 2017a; Iadecola, 2017; Mishra, 2017). Much interest exists in how
the properties of NVC may vary across this so called vascular tree, and in the cellular
mechanisms and signalling pathways that underlie the communication between activated
neurons and the vasculature. Despite the wide body of research that exists on this subject,
many controversies and uncertainties still abound.
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1.1.1 Signalling Pathways
Historically it was believed that this blood flow increase, observed in response to an
increase in neuronal activity, was as a result of a negative feedback loop whereby metabolic
changes would signal an increase in blood flow. However increasing blood oxygen levels
and decreasing blood glucose levels did not alter the increase in blood flow in response to
neuronal activity (Powers et al., 1996; Lindauer et al., 2010). Numerous studies, such as
those demonstrating blood flow changes in response to glutamate (Fergus and Lee, 1997),
have enabled us to conclude that it is, in fact, a primarily feed forward mechanism that
results in blood flow increases following the release of vasoactive messengers. Various
mechanisms have been identified in this process, both direct neuronal effects on the
vasculature, as well as astrocyte-mediated pathways. Despite the multitude of studies
that exist, uncertainty still prevails when it comes to identifying the exact pathways
involved, the timing and the site of action.
Effect of pial innervation and subcortical inputs on vascular tone: Pial arteries are
highly innervated by peripheral nerves which can release vasoactive substances, and
in the cortex, the vasculature receives input from subcortical areas (basal forebrain,
locus correleus, raphe nucleus), resulting in the release of vasoactive substances such as
acetylcholine (Ach), noradrenaline (NA) and serotonin respectively. These innervations
are thought to affect cerebral blood flow (CBF) over large regions and likely contribute
more to resting vascular tone rather than the neurovascular coupling response (Hamel,
2006; Mishra, 2017; Iadecola, 2017).
Excitatory neuronal control of vascular tone: Glutamate has been long been shown
to cause local vascular dilations (Fergus and Lee, 1997) and this combined with the
knowledge that much of the energy supply used by the brain is at postsynaptic glutamate
receptors (Howarth et al., 2012), means that the mechanism behind glutamate evoked
vascular responses is of particular interest. Direct neuronal effects on the vasculature
occur as a result of glutamatergic activation of postsynaptic N-methyl-D-aspartate
(NMDA) receptors. The subsequent rise in intracellular Ca2+ activates nitric oxide
synthase (nNOS) to produce nitric oxide (NO), resulting in a vasodilation in SMCs as
a result of the produced cyclic guanosine monophosphate (cGMP) (Attwell et al., 2010;
Busija et al., 2007). As well as this primary pathway, direct neuronal modulation of the
vasculature arises from the release of the SMC relaxant adenosine, as a result of ATP
hydrolysis (Ko et al., 1990; Lovatt et al., 2012) and the release of potassium from neurons
during the repolarisation phase of the action potential via a variety of K+ channels. The
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potassium acts upon the vasculature to hyperpolarise the SMCs present on arterioles,
causing a vasodilation (Longden et al., 2017).
Astrocytic control of vascular tone: Glutamate also modulates vascular tone via astro-
cytic signalling. Astrocytes are well positioned to mediate the neurovascular coupling
response as their endfeet are wrapped around much of the vasculature. In response to
neuronal glutamate release, there is an increase in astrocytic calcium and a downstream
modulation of vascular activity. However some debate exists over the timing of the
astrocytic response, with some groups reporting calcium changes in astrocytes that
occur after vascular dilation (Nizar et al., 2013), suggesting they would be too slow to
be responsible for the functional hyperaemia response. Other groups have found rapid
calcium signalling in astrocytes (Lind et al., 2013), as well as the slow responses, that
mean they could indeed play a role in the neurovascular coupling response, see Mishra
(2017) for a review. A study from Mishra et al. (2016) has helped to shed light on the
specific, previously unclear, mechanisms underlying astrocytic control of vascular tone by
identifying that astrocytes are essential for signalling to capillaries but that this identified
signalling pathway did not contribute to vascular changes observed at the arteriole
level. In this elegant study, calcium increases in the astrocyte (that were found to be
independent of calcium increases in the neuron as a result of NMDA receptor activation),
as a result of glutamatergic synaptic activity and subsequent post synaptic ATP release,
were found to be necessary for dilation of capillaries but not arterioles. This dilation
was found to be mediated by the activation of the P2X1 receptor on astrocytes, not the
activation of mGluR1 or mGluR5 receptors that were originally thought to be involved.
Following the increase in Ca2+, arachidonic acid (AA) was produced via a phospholipase
D2-phosphatidic acid-diacylglycerol (PLD2-PA- DAG) pathway. The AA was metabolised
to the vasodilator prostaglandin E2 (PGE2) by cyclooxygenase -1 (COX1) and thus acted
on the EP4 receptor present on pericytes, resulting in vasodilation. This pathway was
found to be distinctly different to that which mediates arteriolar dilations, blocking the
NMDA receptors and NOS strongly reduced arteriolar dilations, unlike capillary dilations,
and chelation of astrocytic calcium, which diminished capillary dilation, had no effect
on the observed arteriolar dilation. This study demonstrated two distinct pathways by
which glutamate signals to the capillaries and arterioles. They also suggested that AA
may also be metabolised to epoxyeicosatrienoic acids (EETs) or prostaglandins (PGs)
that could act on the arteriolar component (Mishra et al., 2016). AA itself may also
directly act on vascular SMCs to produce the vasoconstrictor 20-hydroxy-eicosatetraenoic
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acid (20-HETE) although its formation is inhibited by NO. Similar to the mechanism
described above following neuronal K+ release, there is also thought to be a dilatory
effect due to the release of K+ from astrocytic endfeet, ensuing an increase in intracellular
calcium, and the resultant activation of large conductance Ca2+-activated K+ channels.
This K+ acts upon the vasculature to hyperpolarise the vascular SMCs (Filosa et al.,
2006).
Interneuron control of vascular tone: In addition to glutamate released from excitatory
neurons, evidence is emerging highlighting a role for inhibitory interneurons in the neur-
ovascular coupling response via the vasodilator NO and the vasoconstrictor neuropeptide
Y (NPY) (Cauli et al., 2004; Cauli and Hamel, 2010). A study using optogenetic
activation of interneurons, induced an increase in CBF similar to that seen in response
to a sensory stimulation as well as producing a constriction that was attributed to NPY
(Uhlirova et al., 2016). In addition, it has been demonstrated that the selective activation
of nNOS- or SST-expressing interneurons results in haemodynamic changes, showing that
there is a role for interneurons in modulating vascular tone (Lee et al., 2020) .
Low oxygen levels modulate vascular tone: Oxygen levels also affect NVC, at low [O2]
there is an increase in lactate release by monocarboxylate transporters, preventing
the reuptake of the vasodilatory PG, resulting in vasodilation (Gordon et al., 2008)).
There is also an increase in adenosine production, which itself is vasodilatory and also
inhibits the vasoconstrictor 20-HETE. Low [O2] may also limit the amount of NO and
20-Hydroxy-icosatetraenoic Acid (20-HETE) that is produced (Attwell et al., 2010).
Finally, low oxygen levels cause red blood cells to increase their deformability and thus
increasing flow through capillaries (Wei et al., 2016), demonstrating the varied roles [O2]
levels have in modulating the neurovascular coupling response. Interestingly, these studies
show that, although the trigger for the functional hyperaemia is likely feed forward as
discussed above, there may also be a metabolic feedback modulation of the response.
The role of Caveolae:A recent study from Chow et al. (2020), showed the presence of
caveolae, small “pits” in the plasma membrane, in arteriole endothelial cells that are
absent in capillary endothelial cells. The primacy of these caveolae in the arteriolar
dilation in response to a sensory stimulation was highlighted, however their exact role
remains unclear. The investigators demonstrated that the mechanism is independent of
NO signalling and given the ability of caveolin 1 deficient mice (that lack caveolae in
the arteriolar endothelial cells) to vasodilate in response to NO, it is unlikely that the
caveolae provide a membrane reservoir to facilitate vasodilation, as postulated previously.
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The authors suggest that it is likely that the caveolae may cluster ion channels that play
a role in NVC and this may aid the transmission of vasodilatory signals to smooth muscle
cells, but ultimately the mechanism and cell signalling pathways remain unknown(Chow
et al., 2020).
In summary, the signalling pathways involved in neurovascular coupling are com-
plex and multifaceted and depend on a number of variables such as the vascular



























































































































































































































































































































































































































































































































































































































































































































































































































































































































1.1.2 Propagation of Signals
These vasoactive messengers produced following neuronal activation within the brain tissue
are unlikely to have the ability to travel the relatively long distances to the large surface
pial arteries and arterioles. Nevertheless, these vessels are important in the execution of
the neurovascular response, dilating in response to neuronal activity, supporting the idea
that there must be a degree of signal propagation from somewhere else in the vascular tree
(Kisler et al., 2017a). In contrast to the pial arteries and arterioles, brain capillaries are, on
average, <15µm from the closest neuronal cell body (Tsai et al., 2009a), meaning they are
ideally positioned to sense signals released by neuronal activation and communicate these
dilations upstream. In 1997, a study in rats demonstrated that stimulation of cerebellar
fibres produced an increase in vascular diameter and CBF upstream from the activated
area, in the absence of local field potential (LFP) changes next to these upstream vessels
(Iadecola et al., 1997). This idea of a retrograde conduction of vascular signals from the
activated area to upstream vessels was bolstered by Chen et al. (2014) who demonstrated
the critical role endothelial cells play in conducting this response by selectively disrupting
endothelial cells in a single pial arteriole that had previously dilated in response to sensory
stimulation. This disruption resulted in an attenuated response to stimulation, showing
the key role for endothelial cells in the propagation of these signals (Chen et al., 2014).
Evidence shows that inward rectifier potassium channels (KIR), specifically those from
the KIR2.1 subfamily, are key mediators in propagating the dilatory response. Capillary
endothelial cells are enriched with KIR2.1 channels, which are sensitive to K
+ released from
neighbouring synapses or from the encasing astrocytic endfeet. In one study, when K+
was applied to capillaries, a robust dilation was recorded in upstream arterioles as a result
of the rapid activation of the KIR2.1 channels and a subsequent retrograde transmission
of a hyperpolarising signal to upstream arteriolar smooth muscle via myoendothelial gap
junctions. In vivo studies further buttressed the role of KIR2.1 channels as key players
in the propagation of this hyperpolarising signal, as increases in CBF in response to the
application of K+ and haemodynamic responses to sensory stimulation were blunted in
endothelial cell KIR2.1
-/- mice, as well as in the presence of the relatively specific KIR2
blocker, barium (Longden et al., 2017).
In light of this evidence, it is likely that the functional hyperaemia response consists of
two elements, the local response following the release of vasoactive messengers from nearby
astrocytes and neurons as well as a propagated component originating from downstream
vessels.
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1.1.3 Site of signal initiation
As well as propagating signals, a further role for capillaries in the functional hyperaemia
response is a source of much debate in the field, specifically whether or not they
themselves actively dilate in response to neuronal activity, and what role pericytes play
in this. Pericytes are cells which are present along the walls of capillaries and whose
roles are multifaceted, including maintenance of blood brain barrier (BBB) integrity,
angiogenesis, glial scar formation and blood flow control in the brain (Attwell et al., 2016;
Hall et al., 2014). Canonically, the neurovascular coupling response was thought to be as
a result of arteriolar smooth muscle dilation, however a convincing body of evidence has
emerged endowing brain capillaries with the ability to actively dilate to increase blood
flow, as a result of the relaxation of capillary pericytes (Peppiatt et al., 2006; Kisler et al.,
2017b; Hall et al., 2014; Mishra et al., 2016). Pericytes actively respond to synaptic
activation with calcium decreases (Rungta et al., 2018), capillaries that branch directly off
penetrating arterioles (termed 1st order capillaries) dilate to sensory stimulation before
the connected arteriole, suggesting that they actively dilate, rather than in response to
upstream pressure changes (Kisler et al., 2017b; Hall et al., 2014; Cai et al., 2018) and
dilations have been shown to be more frequent and larger at pericyte locations compared
to locations where pericytes are absent (Kisler et al., 2017b; Hall et al., 2014). In a
mouse model of pericyte deficiency, Kisler et al. (2017b) found neurovascular coupling
responses to be blunted and hypoxic pockets were observed in the parenchymal tissue
(Kisler et al., 2017b), however in a similar study from (Watson et al., 2020) the only
difference they observed in the same pericyte deficient model was an increase in blood
flow through the capillary bed. It is thought that these incongruous findings could be
attributed to differences in mouse background and therefore severity of the pericyte loss
(Watson et al., 2020). Indeed in a recent preprint from the same laboratory, they use
optogenetic approaches to conclude that pericytes may indeed contribute to the slow
regulation of flow within capillaries (Hartmann et al., 2020). Despite this body of work,
arguments against there being an active role for pericytes in the dilation of capillaries
and modulation of CBF in response to neuronal activity, still exist (Wei et al., 2016;
Fernández-Klett et al., 2010; Hill et al., 2015).
A large share of this debate exists due to disagreement over the nomenclature of pericytes.
Pericytes are morphologically heterogeneous (Attwell et al., 2016; Grant et al., 2019) with
smooth muscle cells on the arteriolar side which posses wide processes and no visible cell
body. The SMCs transition to pericytes with visible soma and circumferential processes,
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with classically termed “bump on a log” morphology, these processes become increasingly
longitudinal and eventually become stellate in their morphology at the venular side (At-
twell et al., 2016). These various pericyte subtypes are not only morphologically varied
but they also differ in their contractile machinery, with the circumferential processes
on lower branching orders (i.e. those closer to the penetrating arterioles) containing
more smooth muscle α-actin (αSMA) (Attwell et al., 2016; Grant et al., 2019). In one
study, these αSMA containing pericytes were reclassified as “pre-capillary smooth muscle
cells”, leading researchers to inevitably conclude that pericytes were non-contractile and
therefore did not play a role in the control of blood flow in the brain (Hill et al., 2015).
In an attempt to standardise the semantics used when describing pericytes, subtypes
have been termed “ensheathing pericytes”, which are present on lower order branches
(i.e. those closer to the penetrating arteriole), have a high level of vessel coverage,
posses αSMA and are generally accepted to be contractile. “Mesh pericytes” are present
on higher order branches with intermediate vessel coverage and no αSMA and finally,
“thin-strand” pericytes, also on higher branch orders with long thin processes and again,
posses no αSMA (Grant et al., 2019). As aforementioned, it is a subject of controversy
whether or not the mesh and thin strand pericytes have the ability to contract or dilate
capillaries and indeed debate exists on whether or not capillaries even actively dilate,
rather than their diameter change being a passive response to an upstream dilation.
Several groups refute the evidence previously discussed, and have failed to see the dilation
of capillaries (Hill et al., 2015; Wei et al., 2016; Longden et al., 2017). Perhaps this was
due to methodological differences such as animal preparation, imaging resolution or the
presence of a pericyte on the imaged capillary sections, or perhaps these differences in
results arise from variations in the nomenclature used to define vessels, highlighting the
need for careful interpretation of results and a clearer definition of where an arteriole
transitions into a capillary. Although reported capillary dilations are small, they were
estimated to account for 84% of the flow increase in response to neuronal activation (Hall
et al., 2014) and unsurprisingly they offer the greatest resistance across the vascular tree
(Gould et al., 2017), making them important mediators of the NVC response. A further
role for pericytes in the alteration of vascular tone was proposed by Longden et al. (2017),
who suggested pericytes could amplify the electrical signals from KIR signalling during
their transmission to the arteriole upstream (Longden et al., 2017).
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In summary, neurovascular coupling is a complex process that is modulated by many
factors that differ across the vascular tree (see figure 1.2 for summary) but, together, al-
low for the fine control of local blood supply in response to synaptic activity, facilitating
the delivery of the oxygen and glucose required to maintain neuronal function and health.
Disruptions to this delicate control of blood supply are thought to play a role in patho-
logical disease states such as amyotrophic lateral sclerosis (ALS), Parkinson disease and
several dementias, including Alzheimer’s disease, which is the focus of this thesis (Iadecola,
2017).
Figure 1.2: Neurovascular coupling mechanisms vary across the vascular tree. Adapted
from (Iadecola, 2017).
1.2 Alzheimer’s Disease
Alzheimer’s Disease (AD) is the most common form of dementia with most cases present-
ing in older adults (termed “late onset AD” (LOAD)) however a small number of cases
do occur in early life (“Early onset AD” (EOAD)). In the UK, there are estimated to be
850,000 people living with dementia and this number is expected to rise to two million
by 2050, with one in three people born this year expected to go on to develop dementia
in their lifetime (ARUK, 2019). Needless to say, it is an enormous social and economic
issue, with little available in the way of therapeutics. AD is characterised by memory loss
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and cognitive decline, brain atrophy, neuronal damage and specifically, by two patholo-
gical hallmarks, β-amyloid (Aβ) extracellular deposition, and the intracellular deposition
of hyperphosphorylated tau (De Strooper and Karran, 2016). One of the multitude of
challenges faced by AD researchers is the insidious nature of the preclinical phase of the
disease, with changes to the brain’s structure and function, as well as the deposition of the
aforementioned pathological hallmarks of the disease, Aβ and hyperphosphorylated tau,
occurring many years prior to symptom onset (Long and Holtzman, 2019). The existence
of this preclinical phase highlights the importance of investigations into the early stages
of AD and may offer the best window for therapeutic intervention.
1.2.1 Pathological features of AD
Amyloid Beta
Aβ is produced in neurons as a result of the proteolytic cleavage of amyloid precursor
protein (APP) by β- and γ-secretases, in the amyloidogenic pathway (Haass, 2004). Al-
ternatively, in the non-amyloidogenic pathway, APP is cleaved in the middle of the Aβ
region by α-secretase (Haass et al., 2012; Esch et al., 1990; Wang et al., 1991). As these
two pathways compete with each other, α-secretase has been identified as a potential
therapeutic target to reduce Aβ production (Coman and Nemeş, 2017). Aβ is prone to
aggregation, forming oligomers and fibrils, eventually depositing as plaques (Long and
Holtzman, 2019). Aβ has canonically been the focus of much AD research and it was
suggested by Hardy and Higgins (1992), in the amyloid cascade hypothesis, that this de-
position of Aβ in the brain may be the initial trigger in AD, leading to a cascade of
pathological events such as tau hyperphosphorylation and cognitive decline. Since then
however, it has become clear that despite its unequivocal role in the disease process, there
are many more factors at play as various anti-amyloid drugs have failed in clinical trials
to improve the impairments seen in AD (Karran et al., 2011). Additionally the degree of
deposition of Aβ does not correlate with cognitive decline (Nelson et al., 2012) however,
it does seem to be important in the initiation of the disease process, with tau pathology
being dependent on Aβ deposition (Price and Morris, 1999; Price et al., 2009).
Tau
Tau is a soluble, natively unfolded protein that is expressed in neurons and is thought to
be physiologically important in microtubule assembly and transport, as well as axonal sta-
bility (Dixit et al., 2008; Weingarten et al., 1975). Under certain conditions, tau becomes
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phosphorylated, aggregating into oligomers, then paired helical filaments and finally form-
ing tangles (Goedert et al., 2017; Mandelkow et al., 2007). This aggregated tau behaves
in a prion-like manner, where it seeds the aggregation of unfolded tau. In addition, it is
secreted as a result of electrical activity and so can travel synaptically to connected regions
(Goedert et al., 2017; Calafate et al., 2015; Long and Holtzman, 2019). Cognitive decline
is observed when tau pathology spreads to the neocortex from the entorhinal cortex, (Aβ
pathology is required for this transition) (Price and Morris, 1999; Price et al., 2009; Wang
et al., 2016) and from there tau correlates well with cognitive deficits, for that reason it is
thought to be an important driver in the disease process (Nelson et al., 2012).
1.2.2 Risk Factors for AD
There are a number of factors that can increase or decrease the risk of going on to develop
AD. The greatest risk is age, the older you become the more likely you are to develop the
disease (ARUK, 2019). As well as this, there are a number of genetic risk factors that are
also currently considered “non-modifiable”. These include mutations that result in early
onset AD such as PSEN (presenilin)1, PSEN2 and APP mutations (Silva et al., 2019;
Livingston et al., 2017). As presenilin is a subunit of the γ-secretase, these mutations
are thought to involve aberrant APP processing (De Strooper and Karran, 2016). The
greatest genetic risk factor for developing late onset Alzheimer’s Disease, is the ε4 allele
of the Apolipoprotein E gene (Corder et al., 1993; Livingston et al., 2017), which has
multiple effects that may explain why it elevates the risk of developing AD, including effects
on the vasculature. In addition to genetic risk factors there are also many factors that
are considered to be potentially“modifiable”, many of which have a vascular component
and are also risk factors for cardiovascular disease. These modifiable risk factors include
diabetes mellitus, hypertension, obesity, smoking, poor diet, depression and dyslipidaemia
(Crous-Bou et al., 2017; Livingston et al., 2017; Silva et al., 2019).
1.2.3 Alzheimer’s Disease and the Vasculature
Many risk factors for AD are shared risk factors for cardiovascular diseases and there is a
convincing body of evidence to suggest that there is vascular dysfunction in Alzheimer’s
disease. Vascular perturbations are observed early in the disease process, before early
mild cognitive impairment, with studies reporting vascular disruptions prior to the
metabolic, functional, structural, pathological and cognitive changes observed in AD
(Iturria-Medina et al., 2016).
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Hypoperfusion in the early phase of AD has been shown to follow a similar pattern
to Aβ deposition in the parenchyma (Love and Miners, 2016). Capillary blood flow
stalling in a small number of capillaries (∼2%) has been shown to contribute to a global
reduction in CBF observed in mouse models with APP overexpression (Cruz Hernández
et al., 2019), this stalling was shown to be as a result of neutrophils adhering in these
segments. Astonishingly, clearing these few stalled capillaries resulted in a 13% increase
in CBF, bringing the mice to around two-thirds of the normal flow, showing that capillary
stalling is likely to contribute to a significant portion of the CBF deficits we see in APP
over-expressing mouse models. On top of these transient blockages that were noted in
capillaries, there is also an increase in the number of “string” vessels in the brains of AD
patients. String vessels are devoid of endothelial cells and therefore cannot support blood
flow (Brown, 2010).
The blood brain barrier is a specialised structure that plays an essential role in the
protection of neurons from blood-derived products, however in AD patients and in mouse
models that mimic elements of the disease, proteins such as fibrinogen, prothrombin,
albumin and immunoglobulin have been found to leak into the brain parenchyma from
the blood (Ryu and McLarnon, 2009; Zipser et al., 2007; Sweeney et al., 2018b; Montagne
et al., 2017). Many of these blood-derived proteins are neurotoxic and so contribute to
the neurodegeneration seen in AD (Sweeney et al., 2018b).
As well as providing a physical barrier between the blood and the parenchyma, the
BBB also plays an important role in the clearance of Aβ from the brain, a process that
is inhibited in AD (Mawuenyega et al., 2010). Transportation of Aβ from the brain
parenchyma to the blood, in order to be cleared away, is primarily via the low density
lipoprotein receptor related protein-1 (LRP1 receptor) (Deane et al., 2004; Shibata et al.,
2000), however in AD brains and as a direct result of Aβ, there is a decrease in LRP1 in
microvessels (Donahue et al., 2006; Shibata et al., 2000), and LRP1 has been shown to
be oxidised in AD (Owen et al., 2010) which may result in a loss of function. Conversely,
the receptor for advanced glycation end products (RAGE), which is responsible for the
transport of Aβ in the opposite direction, i.e. from the blood into the parenchyma (Cai
et al., 2016), is upregulated in AD brains (Donahue et al., 2006).
Clearance of Aβ across the BBB is only one of several clearance mechanisms utilised by
the brain, it is also cleared via a para- /peri- vascular pathway (Iliff et al., 2012; Bacyinski
et al., 2017; Carare et al., 2020), a process which has been shown to be defective in AD
and in cases of cerebral amyloid angiopathy (CAA; where Aβ deposits around blood
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vessels (Vinters, 1987)) (van Veluw et al., 2019; Weller et al., 2009; Peng et al., 2016;
Arbel-Ornath et al., 2013; Di Marco et al., 2015). Although this clearance process is
not completely understood and many controversies involving the underlying mechanisms
exist, the oscillation of blood vessels is thought to be important, as an interruption of
vascular oscillations results in a reduction clearance (Iliff et al., 2013) and may lead to
an increase in Aβ accumulation (Garcia-Alloza et al., 2011). Oscillations at ∼0.1Hz are
called vasomotion and is key in this clearance mechanism as demonstrated by van Veluw
et al. (2019). They showed reduced clearance in mice with CAA compared to WT mice,
that correlated strongly with the power at the vasomotion frequency (0.1Hz) (van Veluw
et al., 2019). Overall this reduction in Aβ clearance contributes to a build up of the
protein and eventually the deposition of plaques.
Many studies have used both mouse models and human subjects to examine the relation-
ship between Aβ, vascular tone and the functional hyperaemia response. One elegant
study from Nortley et al. (2019), demonstrated that the addition of Aβ to human tissue
resulted in a marked constriction of capillaries but not arterioles. Using pharmacological
methods, they gleaned that this constriction was as a result of the generation of reactive
oxygen species and the downstream release of endothelin-1 which acted on ETA receptors
present on pericytes, evoking a capillary constriction. This effect of Aβ was reinforced
by the finding that blood vessels in both animal and human tissue with Aβ present, had
diameters that increased as a function of pericye soma distance, in direct contrast to
tissue that had no Aβ deposits (Nortley et al., 2019). Further evidence that there is an
interaction between pericytes and Aβ comes from Sagare et al. (2013), where pericyte
deficient mice were crossed with mice overexpressing the Swedish mutation of human
Aβ-precursor protein (Pdgfrβ+/- APPsw/0). When compared with mice that had normal
pericyte coverage, the Pdgfrβ+/-APPsw/0 mice displayed a plethora of deleterious effects
including a reduction in pericyte coverage, accelerated Aβ pathology, the development of
tau pathology and cognitive deficits. In addition, it was found that Aβ accumulated in
pericytes, and if this occurred in excess, lead to cell death (Sagare et al., 2013).
The importance of pericytes in the neurovascular coupling response has been previously
highlighted, so unsurprisingly a number of functional studies have shown the neurovascu-
lar coupling response to be attenuated in a mouse models of Aβ deposition (van Veluw
et al., 2019; Niwa et al., 2000; Iadecola et al., 1999; Zhang et al., 1997). The role of
pericytes in the blunting of these responses has yet to be fully elucidated and various
other mechanisms have been suggested, such as a reduction in vascular smooth muscle
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cell density (van Veluw et al., 2019), superoxide production (Iadecola et al., 1999) and
NADPH oxidase production which was shown to result in endothelial damage (Park
et al., 2014, 2005).
Thus far, much of the focus of research into vascular dysfunction in AD has centred around
the effects of Aβ, with tau, the other pathological hallmark of the disease, being largely
ignored. Some studies have utilised the Tg4510 tauopathy mouse model (which carries
a mutation associated with frontal temporal dementia (FTD)) to probe the question -
how does tau affect the neurovasculature? One study found this mouse model to have
increased angiogenesis with an upregulation of a specific gene, PAI-1, that is important
in extracellular remodelling during vascular formation (Bennett et al., 2018), and another
group has reported BBB leakage in the same model that was ameliorated upon the
suppression of tau (Blair et al., 2015). Further, analysis of human tissue has shown that
tau oligomers accumulate in the cerebrovasculature of AD patients (Castillo-Carranza
et al., 2017) and that vascular remodelling takes place in a manner that correlates with
Braak tau pathology (Merlini et al., 2016). Recent work from Park et al. (2020) has
taken the first step to elucidate the effect of tau on the neurovascular coupling response.
In this novel study it was found that pathological tau (in mouse models associated with
FTD) disrupted the association between nitric oxide synthase and postsynaptic density
protein 95 (PSD95), the protein that enables the coupling of NMDA receptor activation
and nNOS production, leading to a vasodilation as a result of the produced NO. This
disruption between PSD95 and nNOS results in an inhibition in the NO production
and so a reduction in the neurovascular coupling response. Despite this finding, more
evidence is required to fully understand the impact tau has on the neurovasculature and
the functional hyperaemia response, particularly in the presence of non-mutated tau, as
in AD (Bonnar and Hall, 2020).
This wide body of work provides indisputable evidence that there is vascular dys-
function in AD, across different compartments of the vascular tree, and attests the
importance of further research in this field. In addition to the demonstrable negative
effects of AD pathology on the vasculature, understanding how the APOE4 gene increases
the risk of developing AD, in the absence of Aβ and pathological tau, and understanding
if effects on the blood vessels contribute to this risk, will be essential in bettering our
understanding of the disease.
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1.3 apolipoprotein E
The presence of the gene encoding for apolipoprotein E (APOE) 4 is the greatest genetic
risk factor for going on to develop late onset AD (Corder et al., 1993). Three APOE iso-
forms exist, ε2, ε3 and ε4, with two alleles of ε4 increasing disease risk 9-15 fold (Yamazaki
et al., 2019; Farrer, 1997), despite an ε4 allele frequency of 14% in healthy individuals, it
is over represented in AD patients with a frequency of 38% (Yamazaki et al., 2019; Corder
et al., 1993). ApoE is a 34kDa protein, consisting of 299 amino acids and each isoform
differs by only one amino acid at two residues. ApoE2 has a cysteine at position 158 and
112, ApoE3 has a cysteine at position 112 and arginine at 158 and ApoE4, an arginine
at 112 and 158. These polymorphisms impact the structure and function of each ApoE
isoform (Bu, 2006). Peripheral ApoE is produced mainly in the liver and in the central
nervous system (CNS) it is produced primarily by astrocytes but also by vascular mural
cells, microglia and neurons under stress conditions (Xu et al., 2006; Bu, 2006; Casey et al.,
2015). ApoE plays an important role in the transport of cholesterol and other lipids to
neurons, mediated by receptors of the LDL family. ApoE mostly exists in association with
lipids, something that functionally important as its lipidation is essential for its binding
with the LDL receptors (Hauser et al., 2011).
The role of APOE in the pathobiology of AD is still not completely understood but its
stature as the greatest known genetic risk factor for the development of AD makes it of
great interest to researchers. Much existing research implicates APOE4 in the facilitation
of Aβ aggregation and the prevention of its clearance, however in addition to these effects,
there is also a clear interaction between APOE and the brain’s vasculature.
1.3.1 APOE and Aβ
Evidence shows that ApoE and Aβ are inextricably linked with the influence of ApoE on
the deposition of Aβ suggested by the finding that the low levels of cerebrospinal fluid
(CSF) ApoE, as seen in ApoE4 carriers (Cruchaga et al., 2012), correlates with increased
Aβ deposition, suggesting that low ApoE levels may promote this deposition. With re-
gards to ApoE binding, it has been suggested that Aβ may compete with lipids (Kanekiyo
et al., 2014) and may affect its ability to transport lipids properly, something that is es-
sential for synaptic health (Bu, 2006).
APOE4 carriers have been shown to have an increased Aβ plaque burden (Kok et al.,
2009; Polvikoski et al., 1995), elevated levels of oligomeric Aβ (Koffie et al., 2012) and
increased CAA (Nelson et al., 2013; Pfeifer et al., 2002), when compared to APOE3 or
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APOE2 carriers, as well as an increased quantity of Aβ per affected vessel, increasing the
chances of vessel rupture (Alonzo et al., 1998). This is thought to be mostly as a result of
altered Aβ clearance as well as the increased propensity of Aβ to aggregate in the pres-
ence of ApoE4 (Castano et al., 1995; Ma et al., 1994). As previously mentioned, the BBB
and paravascular clearance pathways are important in the clearance of Aβ, it can also be
cleared by enzymatic degradation, by neprilysin and insulin degrading enzyme, as well as
by lysosomal breakdown in glial cells (Safieh et al., 2019).
ApoE affects Aβ clearance in an isoform dependent manner (Castellano et al., 2011), firstly
when looking at the clearance of Aβ across the BBB, ApoE4 binds to LRP1 with poor
affinity (Bell et al., 2012) meaning that the clearance of APOE4 and Aβ complexes are
redirected to the VLDL receptor where they are cleared at a slower rate across the BBB
when compared to ApoE2-Aβ and ApoE3- Aβ complexes which are cleared by both the
LRP1 and VLDL receptors (Bell et al., 2007; Deane et al., 2008). Additionally, paravascu-
lar clearance of Aβ was found to be disrupted in ApoE4 mice, compared to ApoE3 mice,
as injected Aβ accumulated in the clearance pathways in APOE4 mice (Hawkes et al.,
2012).
Glial degradation of Aβ is also reduced in APOE4 carriers. In a study examining peri-
cytes co-cultured with astrocyte-derived ApoE3 or ApoE4, it was shown that pericyte
uptake and clearance of Aβ is isoform dependent, with the clearance of Aβ in the pres-
ence of ApoE4 reduced, compared to ApoE3 (Ma et al., 2018). In addition to pericytes,
astrocytes also uptake Aβ, contributing to its clearance. However it has been shown that
APOE4 iPSC-derived astrocytes are less efficient at taking up Aβ42 compared to APOE3
iPSC-derived astrocytes (Lin et al., 2018). The degradation of Aβ by neprilysin in mi-
croglia is also less efficient in the presence of ApoE4-containing high-density lipoprotein
(HDL) particles, compared to ApoE2- or ApoE3-containing particles (Jiang et al., 2008)
and ApoE4 reduced levels of insulin-degrading enzyme compared to ApoE2 or ApoE3
(Cook et al., 2003; Du et al., 2009). These studies converge to show that the presence of
ApoE4 facilitates the accumulation and aggregation of Aβ, primarily due to the failure of
a number of clearance mechanisms.
1.3.2 APOE and Tau
Evidence suggests that ApoE and Tau interact in an isoform dependent manner, ApoE4
expression in neurons results in tau phosphorylation to a greater extent than ApoE3
(Brecht et al., 2004), and post-mortem studies of human tissue have shown that APOE4
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carriers have a greater number of tau aggregates than non-carriers but only in the presence
of Aβ (Tiraboschi et al., 2004). In vitro studies using cultured hiPSC-derived neurons,
showed that neurons derived from APOE4 homozygotes produced more phosphorylated
tau than APOE3 neurons (Wang et al., 2018). In a study from Shi et al. (2017), a human
ApoE knock in (APOE-KI) mouse model was crossed with a tauopathy model, P301S,
that is associated with frontotemporal dementia. They showed by 3 months of age,
P301S/E4 mice had higher levels of tau present, as well as going on to develop greater
levels of brain atrophy and inflammation at 9 months than P301S/E2 or P301S/E3
mice (Shi et al., 2017). One mechanism that has been suggested to explain the increase
in tau accumulation in ApoE4 carriers, is that ApoE4 is less effective than ApoE3 in
binding to non-phosphorylated tau and preventing its subsequent hyperphosphorylation
(Safieh et al., 2019). Neuronal ApoE4 is also more vulnerable to proteolytic cleavage,
which results in the production of neurotoxic fragments, these can cause mitochondrial
damage and disruption to the cytoskeleton (Mahley et al., 2006). In addition, evidence
suggests that they also promote the phosphorylation of tau resulting in the formation of
tangle-like structures (Huang et al., 2001; Brecht et al., 2004). In contrast to the findings
of Shi et al. (2017), another study observed that upon injecting AAV- TauP301L, it was
in fact, the APOE2-knock in mice that had the greatest amount of tau pathology and
deficits in behavioural tests (Zhao et al., 2018). These discordant findings have been
attributed to differences in experimental model and levels of tau expression (Najm et al.,
2019; Yamazaki et al., 2019).
These studies show that there is extensive interplay between APOE and the two
pathological features of AD, highlighting its integral role in the disease process.
1.3.3 APOE and the Cerebrovasculature
APOE genotype and cardiovascular risk factors interact to affect cognition and long term
memory. APOE4 carriers have been found to have greater long term memory impairments
that are associated with cardiovascular risk factors (Caselli et al., 2011) and a small rise
in blood pressure in APOE4 carriers is associated with reduced regional brain volumes
and cognitive deficits (Bender and Raz, 2012). In addition, there is an isoform dependent
increase in the risk of developing coronary artery disease and myocardial infarction (e4
>e3) (Belloy et al., 2019). It is possible that dysfunction of the cardiovascular system
associated with ApoE4 may contribute to or even instigate the cognitive decline and
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neurodegeneration observed in AD.
In the prefrontal cortex of human APOE4 carriers, capillary basement membrane area
is lower than that of APOE3 carriers (Salloway et al., 2002). Basement membrane
thinning is thought to be indicative of blood brain barrier leakage and indeed, another
study found lower levels of phosphorylated occludin at Thr residues in an in vitro BBB
model with astrocytes prepared from ApoE4-KI mice compared with those prepared from
ApoE-3 KI mice (Nishitsuji et al., 2011). Phosphorylation of occludin at Thr residues
is essential for its assembly into the tight junctions of the BBB. A multitude of studies
have corroborated these findings and have shown that the BBB is leaky in an isoform
dependent (e4 >e3) manner in humans, in vitro and in mouse models. This has been
measured by increased prothrombin leakage in the prefrontal cortex of patients carrying
at least one APOE4 allele (Zipser et al., 2007) and increases in extravascular IgG and
fibrin in the cortex of APOE4 carriers with AD (Halliday et al., 2016; Hultman et al.,
2013). In the aforementioned in vitro BBB, it was more permeable when astrocytes
were prepared from APOE4 mice, compared to APOE3 mice (Nishitsuji et al., 2011)
and in mouse studies, similar results have been observed. In one seminal study by
Bell et al. (2012), utilising different humanised APOE mouse models, they showed
a reduction in BBB integrity resulting in the deposition of the neurotoxic proteins
thrombin and fibrin in mice expressing humanised ApoE4. This was shown to be as a
result of the upregulation of a proinflammatory Cyclophilin A (CypA)-nuclear factor
(NF)-κB-matrix-metalloproteinase-9 (MMP-9) pathway in capillary pericytes. It was
demonstrated that ApoE4 was unable to suppress this pathway, unlike ApoE2 and
ApoE3, due to its low interaction with LRP1. They accompanied these results with
reports of reduced microvascular length, reduced pericyte coverage, DNA fragmentation
in pericytes and endothelial cells and regional blood flow reductions that, importantly,
preceded any neuronal alterations (Bell et al., 2012). A recent study from the same group
confirmed that this pro-inflammatory mechanism was also present in human APOE4
carriers. APOE4 subjects had increased BBB leakage that correlated with CSF levels of
the pericyte injury marker, soluble PDGFRβ (Montagne et al., 2020). In addition, levels
of CSF MMP-9 and CypA were increased in APOE4 carriers, highlighting the potential
importance of this pathway in the breakdown of the BBB observed in APOE4 animals
and humans.
Congruous with these observations, several other groups have also reported interactions
between ApoE and capillary pericytes. Human pericytes cultured from APOE4 carriers
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were found to be more susceptible to damage when co-incubated with Aβ, than those
cultured from non-carriers (Wilhelmus, 2005) and a reduction in capillary coverage by
pericytes in APOE4 carriers has been reported by other groups in humans (Halliday
et al., 2016), and in mice (Koizumi et al., 2018). One interesting study from Casey et al.
(2015), observed that in the absence of pericytic ApoE, pericyte migration increases
dramatically, an effect that is reversed upon application of exogenous ApoE3 but not
ApoE4. This migration was found to depend on LRP1 and the activation of the protein
RhoA, which has been shown to regulate cell adhesion and migration. Although this
migration is important in the formation of glial scars and angiogenesis, an excess response
may result in depletion of pericytes on capillaries which could alter CBF.
Much of the focus of existing work outlining the interplay between ApoE on peri-
cytes has focused on the effect on BBB integrity and the putative role this plays in
neurodegeneration as a result of the extravasation of neurotoxic substances from the
blood stream. However few groups have investigated the effect of this pericyte damage
on the neurovascular coupling response, in which pericytes have previously been shown
to play a key role. One study that has begin to address this question is from Koizumi
et al. (2018). They use the APOE-TR model, and find, similarly to what was reported
by others, a reduction in pericyte coverage, a reduction in vascular density in 3-4 month
old mice, reductions in cortical CBF and interestingly, a reduced functional hyperaemia
response, as measured by laser Doppler flowmetry, to whisker stimulation. They propose
that the effect of ApoE4 on net CBF responses is endothelium dependent as superfusion
with the endothelium-dependent vasodilators acetylcholine and bradykinin resulted in the
attenuated response observed with the whisker stimulation, however superfusion with the
smooth muscle relaxant adenosine and NO donor s-notroso-N-acetylpenicillamine (SNAP)
did not show an attenuated response in APOE4 mice. They also used three-photon
microscopy to record from the corpus collosum, and showed increased vulnerability of
APOE4 mice to vascular alterations in response to bilateral carotid stenosis (Koizumi
et al., 2018).
A more detailed probe into the neurovascular dysfunction would determine if deficits
occur at a single vessel level, if so, where in the vascular tree they occur and how this
effect is modulated by age. In addition, an examination of neuronal activity in these
animals would help to determine if any changes in the haemodynamics are as a result of
neuronal alterations in APOE4 mice .
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1.3.4 APOE and Neurons
In functional hyperaemia, blood flow increases are commensurate with neuronal demand
and so in order to assess this response in its entirety, it is important to study neuronal
behaviour. Various effects of ApoE4 on the neurons have been observed, although it
remains unclear how these effects interact with the vasculature and the NVC response.
The GABAergic system is an inhibitory system in the brain and regulation of its inhibition
is essential for normal brain function. These interneurons also play an important role in
learning and memory, as well as preventing hyperexcitability of excitatory neurons (Najm
et al., 2019). A reduction in GABA has been shown in post mortem brains of AD patients
and a resulting disinhibition may be responsible for the seizures sometimes observed in
the disease (Lanctôt et al., 2004; Najm et al., 2019). Neurotoxic fragments generated
from the proteolytic cleavage of ApoE4 are particularly damaging to GABAergic neurons
(Li et al., 2009). In a knock-in mouse model of APOE, removing tau rescued the effects
of ApoE4 on interneuron loss, as well as behavioural deficits (Andrews-Zwilling et al.,
2010), demonstrating the interplay between tau and ApoE in this interneuron loss.
In neurons derived from APOE3 or APOE4 hiPSCs, there was no difference in the
generation of dopaminergic or glutamatergic neurons, however there was a degeneration
of GABAergic neurons in ApoE4 vs ApoE3 (Wang et al., 2018), again highlighting the
selective vulnerability of these neurons to ApoE4. Intriguingly, the cellular source of
ApoE seems to be important in this interneuron loss, as deletion of neuronal ApoE4
in GABAergic interneurons prevents the GABAergic neuron loss, however deletion of
astrocytic ApoE4 does not have the same effect (Knoferle et al., 2014).
This selective vulnerability of GABAergic neurons to ApoE4 mediated damage has effects
on network function and results in hyperactivity. ApoE4 patients are at a greater risk of
developing seizures, including those as a result of previous trauma (Johnson et al., 2018;
Diaz-Arrastia et al., 2003) and hyperactivity has been observed in the entorhinal cortex
of APOE-KI mice (Nuriel et al., 2017) and in human subjects a greater level of entorhinal
activation during learning is observed compared to non-carriers (Dickerson et al., 2005).
This collection of evidence demonstrates the selective susceptibility of GABAergic
interneurons to ApoE4 mediated damage, and that there is a critical role for tau in this
process. As a result, hyperactive phenotypes are exhibited among APOE4 carriers and
can affect task performance and memory.
ApoE4 has also been associated with a reduction in dendritic spine density, in both
human carriers (Ji et al., 2003) and in APOE4 mouse models (Ji et al., 2003; Rodriguez
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et al., 2013; Dumanis et al., 2009). As well as this, human carriers have shown reduced
synaptic plasticity (Arendt et al., 1997), fewer synaptic markers and a reduced post
synaptic density in healthy APOE4 carriers (Love and Miners, 2016) and a reduced
number of glutamate receptors (Sweet et al., 2016). In line with these findings, mouse
models have shown ApoE4 to be associated with a reduction in synaptic proteins e.g.
vGLUT the presynaptic glutamatergic vesicular transporter (Liraz et al., 2013), reduced
synaptic transmission (Wang et al., 2005), and reduced neurite outgrowth possibly as a
result of lower activation of LRP1 by ApoE4 (Nathan et al., 2002). Demonstrating that
ApoE4 has an array of deleterious effects on the synapse which is likely to be strongly
associated with the cognitive decline observed in AD.
It is clear that ApoE4 may increase the the risk of AD via a number of harmful
mechanisms (see figure 1.3 for a summary) that are likely to converge and result in the
neurodegeneration observed in AD. Although it is clear that there is a role for vascular
dysfunction among this, it remains to been seen exactly how the NVC is modulated by
ApoE and what downstream effects may result.
Figure 1.3: Various APOE4 pathways that likely contribute to the neurodegeneration and cognitive
decline observed in AD. Modified from Safieh et al. (2019).
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1.4 Hypoxia
Altered NVC and CBF could, over time, result in a deficient supply of oxygen within the
brain. There are a multitude of detrimental downstream effects of hypoxia, including the
facilitation of tau hyperphosphorylation (Fang et al., 2010; Chen et al., 2003) and Aβ
accumulation (Sun et al., 2006; Zhang and Le, 2010), disruptions to BBB integrity (Ueno
et al., 2002; Pluta, 2005) and increased neuroinflammation (Liu et al., 2001; Gerhard
et al., 2000), all of which are known to contribute to the neurodegeneration observed in
Alzheimer’s disease.
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1.5 Two Hit Hypothesis of Alzheimer’s Disease
This extensive body of evidence pointing towards a significant contribution of vascular
dysfunction to AD has led to the proposition of the vascular two hit hypothesis by Berislav
Zlokovic. In this hypothesis he suggests that there are two “hits” contributing to the
pathological cascade involved in AD, “hit” one is Aβ independent and involves vascular
dysfunction such as BBB dysfunction, CBF dysregulation and hypoperfusion as a result
of risk factors such as CV disease, diabetes mellitus, hypertension or the presence of
an APOE4 allele. Hit one facilitates the accumulation of Aβ and inhibits its clearance,
resulting in a build up of Aβ pathology in the brain. This is “hit 2” of the hypothesis,
with Aβ exerting neurotoxic effects and triggering tau pathology , finally resulting in the
cognitive decline we see in AD (Zlokovic, 2011) (see figure 1.4) .
Figure 1.4: Two Hit Hypothesis of Alzheimer’s Disease. Hit one: Aβ independent vascular
dysfunction which leads to Hit 2: Aβ mediated neurodegeneration and cognitive decline, finally
resulting in AD. Adapted from Zlokovic (2011).
AD research has classically focused upon Aβ pathology and neuronal damage, however
the evidence outlined above supports the central postulate of perturbed vascular function
in the disease process. The idea that vascular factors could be an early, or even an initial,
trigger of the disease is undoubtedly a credible one and the body of work presented in this
thesis aims to answer some of the outstanding questions relating to the role of ApoE in
the NVC response and how this may contribute to the neurodegeneration and cognitive
decline observed in AD.
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In light of the evidence explored in this chapter, it is clear that there are many knowledge
gaps in our understanding of the effect of ApoE4 on the neurovasculature and how these
interactions might promote AD. Given that previous work suggests APOE4 animals
may exhibit vascular dysfunction in early life, an in depth exploration into neuronal and
vascular function in young animals, at a single vessel and neuronal level, would provide
invaluable information to the field. In order to assess this, resting state conditions first
need to be examined, to determine if APOE4 animals are existing with basal deficits
upon which the functional hyperaemia response is elicited. Following this, the vascular
and neuronal responses to sensory stimulation can be measured, to estimate how energy
demand (from active neurons) and energy supply (via the blood supply) is balanced in
ApoE4 animals. Finally, how these effects might change with age is of great interest, so
tracking these parameters across a section of the lifespan would provide an interesting
insight and help to identify where and when dysfunctions might occur.
Hypothesis : ApoE4 disrupts pericyte function, altering the blood brain barrier, even
in young animals. I predict that this alteration in pericyte function will also disrupt
baseline cerebral blood flow and neurovascular coupling responses to neuronal stimulation.
Because blood brain barrier function deteriorates with time, any observed deficits in
neurovascular effects are also expected to deteriorate with age.
With this in mind, this body of work aims to answer three core questions:
1. Does ApoE4 modulate resting neuronal or vascular properties in young
animals?
2. Does ApoE4 affect the ability of the brain to elicit the functional hyper-
aemia response in young animals?






All animal procedures in the outlined methods were carried out in accordance with the
guidelines of the UK Animals (Scientific Procedures) Act 1986.
All mice were bred in house from targeted replacement (TR) APOE mice, where exons
2-4 of murine APOE were replaced with exons 2-4 of human APOE, resulting in the
production of human ApoE in these animals (Sullivan et al., 1997; Knouff et al., 1999).
APOE3-TR or APOE4-TR homozygotes were subsequently bred with mice expressing
DsRed under the control of NG2 promoter (NG2DsRedBAC) (Zhu et al., 2008), allowing
for the visualisation of vascular mural cells, or with mice expressing GCaMP6f under
the control of the Thy1 promoter (C57BL/6J-Tg(Thy1-GCaMP6f)GP5.5Dkim/J), which
primarily leads to GCaMP expression in subsets of pyramidal neurons (Chen et al., 2012;
Dana et al., 2014) (see table 2.1). These mice were then subsequently backcrossed for
several generations to produce APOE-TR homozygotes and Thy1-GCaMP6f heterozygotes
or APOE-TR homozygotes and NG2DsRed heterozygotes. APOE-TR, NG2DsRed and
Thy1-GCaMP6f founder mice were generously gifted by Sarah King, David Attwell and
Leon Lagnado, respectively. NG2DsRed and Thy1-GCaMP6f animals of the same APOE
genotype were grouped together in all analyses as they did not exhibit robust genotype
differences in the neurovascular parameters measured (see appendix B.5) although group
sizes were not balanced.
Both male and female mice were used and were categorised into three age groups at the
time of experimentation (see table 2.1 for groups and animal weight). Prior to surgery,
mice were group housed in a temperature controlled room (22+/-2◦C) with a 12 hour
light/dark cycle and ad libitum access to food and water. Following the post-surgery
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monitoring period outlined here, mice were singly housed under the same temperature
conditions and with the same access to food and water as before, but under a reverse 12
hour light/dark cycle and with access to a running wheel to aid with habituation to the
imaging rig.
Table 2.1: Mouse genotypes and age categories Experimental mice genotypes and age cat-
egories are outlined above. Not all experiments had data for each genotype at each age point.
Experimental group sizes are specified in Appendix A under each individual experiment.
2.2 Surgical Preparation
All animals used in in vivo experiments underwent an aseptic surgical procedure to im-
plant both a glass cranial window over the primary visual cortex (V1) and titanium head
bars atop the skull which allowed for head fixation.
Isoflurane 4% was used to induce anaesthesia in a chamber, after which animals were
moved to a stereotaxic frame. Here anaesthesia was maintained with ∼1.5 - 2% iso-
flurane, delivered via a nose cone (Kopf) and body temperature was kept at 37◦C by
a homeothermic monitoring system (PhysioSuite, Kent Scientific Corporation). Reflexes
and breathing rates were monitored throughout, and levels of anaesthesia were adjusted
accordingly. Animals underwent subcutaneous injections of saline 0.9% (400µL) to prevent
dehydration, buprenorphine (1.2µg, Vetergesic, Ceva), an analgesic for pain relief, melox-
ican (6.2 µg, Metacan, Boehringer Inglehim), an anti-inflammatory and dexamethasone
(120µg, Dexadreson, MSD Animal Health), an anti-inflammatory steroid. Eye gel (Vis-
cotears Liquid Gel, Novartis) was periodically applied to prevent drying or damage from
particulates.
Hair from the skull area was cut as much as possible using curved scissors before the ap-
plication of hair removal cream to reveal the skin below. Ethanol 70% and the antiseptic,
betadine (Purdue Product, USA) was applied to clean the area. A large, round incision
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was made to revel the entire dorsal surface of the skull below, with a small amount of neck
muscle and any exposed periosteum removed to ensure only bone was exposed. The edges
of the incision were sealed with a tissue adhesive (Vetbond, 3M), and the 3mm craniotomy
site was marked using surgical calipers (Fine Science Tools) and a bone pen (see figure 2.1)
for position). To increase the surface area for head bar adhesion, deep grooves were made
in the skull using a scalpel blade before the head was tilted to lay the craniotomy site
flat. The entire skull surface, excluding the marked site of the craniotomy and ∼1mm
of the surrounding area, was then coated in dental cement (Unifast TRAD, GC; mixed
1:15 with black ink), ensuring thicker layers were added wherever necessary to provide a
flat surface for the placement of the head bars (see figure 2.1 for placement). After a few
moments, the cement hardened and the bars were then fixed in place. The craniotomy
was then made using a 3mm biopsy punch (Kai Medical), by slowly twisting the punch
over the marked site it was possible to entirely remove the desired section of skull. If
necessary a microdrill (OmniDrill 35, World Precision Instruments) with a fine drill bit
(0.5mm, Fine Science Tools) was used to drill through any remaining segments of bone.
When using the microdrill, regular applications of saline to the skull were necessary to
prevent heating of the underlying brain. Following removal of the skull flap, the exposed
brain was immediately covered with gelfoam (Avitene Ultrafoam, Bard Davol Inc., US) to
keep the underlying brain from becoming dry, to keep the area sealed and to control any
bleeding. The dura was carefully removed using super fine forceps (Fine Science Tools)
and the area was again moistened with gelfoam. Glass windows were made from two 3mm
layers of glass coverslip, affixed to a single 5mm coverslip (Harvard Apparatus). The 3mm
side of the window was used to plug the craniotomy with a tight seal and was held in place
temporarily with a glass rod while tissue adhesive and dental cement was applied around
the edges to secure the window in place. Finally, two small rubber rings were glued and
cemented to the outer rim of the head bars to later facilitate the use of a water-based
objective. The level of isoflurane was slowly reduced and the animal was placed in a heat
box at 38◦C to recover. Once awake, grooming and exploring the new home cage, animals
were returned to a temperature controlled recovery room where they were monitored reg-
ularly for three days post-operatively. Animals were administered oral meloxicam (10µg,
Boehringer Ingelheim) in food and weighed daily during this period. At the end of this
three day period, animals were moved to a room with a reverse light/dark cycle and were
allowed a minimum of 1 week of recovery before habituation.
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Figure 2.1: Schematic of craniotomy site and head bar placement Craniotomy site marked
(dashed line), 3mm from the intersection of lambda and the midline. Grey solid line depicts
approximate placement of head bars.
2.3 Habituation
Mice were slowly habituated to head fixation to ensure minimal stress for the animal during
imaging. Habituation occurred over the course of approximately 1 week, depending on
the animal. Initially mice were placed upon the imaging cylinder without head-fixation
so that the environment would become familiar. They would then be briefly head fixed
and gradually the restraint period would increase in duration until the animals could
comfortably walk on the cylinder for extended periods of time.
2.4 In Vivo Experiments
2.4.1 Data Collection
During imaging mice were head-fixed atop a running cylinder as mentioned above, (see
Figure 2.2) where they were free to engage with locomotion. To record locomotion
the cylinder was equipped with a rotary encoder (Kuebler) and this was positioned
under a two-photon microscope (Scientifica) or a combined laser Doppler flowmetry
haemoglobin spectroscopy probe (Oxy-CBF probe) (Moor instruments) that allowed for
the measurement of net haemodynamic parameters across the cranial window. In front of
the mice were two screens (Asus, ∼17cm from the mouse) which displayed visual stimuli
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(delivered using Psychopy) when required.
Two experimental paradigms were employed throughout, a “visual stimulation” paradigm
and a “no visual stimulation” paradigm. The “visual stimulation” paradigm consisted of
the presentation of 20 trials of a drifting grating. The grating was angled at 315◦, made
up of alternating trials with a spatial frequency of either 0.04 cycles per degree or 0.2
cycles per degree (10 trials each), a temporal frequency of 2Hz and sized at 220 degrees
of visual space (i.e. a full screen stimulus). The grating was presented for 5 seconds with
an inter stimulus interval of 20 seconds. The “no visual stimulation” paradigm meant the
mouse was not presented with the gratings described above, but was allowed to engage
with voluntary locomotion while the screens were dark.
Figure 2.2: Schematic of in vivo imaging set up Mice were head fixed atop a cylindrical run-
ning cylinder, underneath a two-photon objective or Oxy-CBF probe and in front of two screens




Prior to two-photon recordings, mice were injected with a fluorescent dextran. Those with
green fluorescence (i.e. GCaMP6f in excitatory neurons) were injected with 2.5 %Texas
Red (neutral, Invitrogen) either subcutaneously (3kDa) or intravenously (70kDa), and
those with red fluorescence (i.e.DSred in vascular mural cells) were injected intravenously
with 2.5% fluorescein isothiocyanate-dextran (FITC-dextran), to allow visualisation of the
vasculature. To aid with intravenous injection, mice were placed in a heated box (38◦C)
for 10 minutes, before being restrained and injected. Vasculature was recorded +/- fluor-
escently labelled neurons, using a 20x (XLUMPlanFL N, Olympus) or 16x (LWD, Nikon)
water immersion objective and a mode-locked Ti-sapphire multiphoton laser (Chameleon,
Coherent). Tissue was excited at either 940nm or 970nm and red and green light was
collected using SciScan (Scientifica) software. Images were captured at an acquisition rate
of 3.8 - 7.6 frames per second for whole vessel (average pixel size : 0.424 µm) or neuronal
population (average pixel size : 1.28 µm) recordings (XY movies), and high speed line
scans were used to concurrently record vascular diameter and red blood cell velocity of
small vessels (average pixel size : 0.195 µm) at an average acquisition rate of 1221 lines
per second. Typically, a large pial arteriole that dilated to visual stimulation would be
identified within the window. The ability of the vessel to dilate helped to confirm where
the active region was and also to confirm the vessel’s identity as an arteriole, rather than
a vein. The presence of fluorescent smooth muscle cells in some cases as well as the mor-
phology (the size and position relative to the large pial veins) of the vessel would also aid
in its identification as a pial arteriole. Each branch of the arteriole was imaged (under
both experimental paradigms) until a branch began to dive into the parenchyma, in which
case, the vessel was no longer considered to be pial, but instead, a penetrating arteriole.
Capillaries branching off the penetrating arterioles and beyond, were imaged using high
speed line scans, again under both experimental conditions (i.e. +/- visual stimulation).
If excitatory neurons were labelled with GCaMP6f, a recording would be taken at the cell
body layer of the cortex (layer 2/3 (∼ z =-150µm), in the area proximate to the imaged
vasculature. Z-stacks were taken to aid in identification of vessels within the network, as
well as to enable the characterisation the vascular anatomy (average frames per plane: 4,
average pixel size:1.28 µm , average z-step: 1.09µm).
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Oxy-CBF probe
Net measurements of the haemodynamic parameters, total haemoglobin (HbT), oxy-
(HbO) and deoxy-(HbD) haemoglobin and oxygen saturation (SO2) could be obtained
(acquisition rate: 40Hz) from the different absorption spectra of HbO and HbD as de-
scribed in Kohl-Bareis et al. (2005). Briefly, a white light of wavelength 450nm-700nm
was emitted from the probe and reflected light was collected with a spectrometer. A
Monte Carlo simulation (Wang et al., 1995) was used to estimate the intensities of the
reflected light and based on the knowledge that the absorption coefficients of Hb0 and
HbD are 20 and 240 times less than the maximum respectively (Kohl-Bareis et al., 2005),





In addition to the haemoglobin spectroscopy, the probe used laser Doppler flowmetry to
calculate blood flow (CBF) across the window. Using these parameters, the cerebral meta-
bolic rate of oxygen consumption (CMRO 2) was calculated using the following equation:
CMRO2 = CBF ×
HbD
HbT
The probe was placed against the glass of the cranial window and net measurements were
taken during both experimental paradigms described above.
2.4.2 Data Analysis
Custom written MATLAB scripts for the extraction of data from raw image files were
co-written by Dr Kira Shaw, Dori Grijseels and I.
Any images deemed to be of poor quality were excluded from further analysis. This was
primarily due to the dye not being bright enough due to fading or a poor injection or in
some cases, areas of the window that were less clear.
Locomotion Detection
Throughout all in vivo experiments, locomotion was detected, as mentioned, by a rotary
encoder. Continuous locomotion traces were obtained for each experiment and traces went
through a number of processing steps. Firstly, the differential and the absolute values for
each locomotion trace were calculated, to remove drift and negative values (from backwards
locomotion), respectively. All values below one standard deviation of the entire trace were
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deemed to reflect noise, rather than real locomotion, and so were set to zero. Finally,
all traces were normalised so that they fell between zero and one, to make them more
comparable between sessions (Figure 2.3).
Figure 2.3: Example Locomotion Traces Left graph: An example trace of raw locomotion.
Right graph: The same locomotion trace that has been processed to remove drift, negative numbers
and noise.
Vascular diameter measurements
Using the FIJI distribution of ImageJ (Schindelin et al., 2012), a number of pre-processing
steps were taken to improve image quality and consistency between vessels. Namely,
wherever required, images were registered to remove motion artefacts, despeckled to re-
move noise and/or median 3D filtered (X, Y and Z radii = 2) to smooth the image.
All images had the “Stack Contrast Adjustment” plug-in applied to brightness match all
frames and so eliminating light artefacts in the data. Light artefacts might arise from
the visual stimulation presentation (although care was taken to block as much light as
possible by shielding the objective with light occluding tape). A custom MATLAB script
was written to extract the diameter in a number of steps. As the vessel was brighter than
the background, a skeleton could automatically be generated and modified by the user.
For every point in the skeleton, a perpendicular line was drawn across the vessel, allowing
for an intensity profile to be generated. Intensity profiles were obtained across a sliding
window of five pixels at every second point in the skeleton. The full width at half max-
imum (FWHM) was calculated for each of the five intensity profiles within each window,
that is, the distance in pixels between the first time the curve crossed the half maximum
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value and the second time it crossed this same value. The five FWHM values were then
averaged to give a single value in pixels for each window and diameters were calculated
by multiplying by pixel size. All diameters for skeleton points within a single frame were
averaged so a continuous diameter trace over time could be extracted (see Figure 2.4 ).
All vascular data traces were inspected by eye for signs of swelling. If swelling occurred
the traces were cut to the period before the swelling began.
Figure 2.4: Pipeline for diameter extraction using FWHM A) Raw vessel file imported into
MATLAB B) Vessel is skeletonised and a perpendicular line is drawn across each skeleton point
C) A sliding window, that moves in steps of 2 pixels, groups together 5 pixels within each window
D) The distance between the FWHM values (red) are taken for each of the five skeleton points
per window and averaged to give one diameter measurement per window. E) Averaged values are
obtained for each skeleton point per image frame. The skeleton points are then averaged together
to give one diameter measurement per frame
Line scan data analysis
Line scan diameter and red blood cell velocity (RBCV) measurements were made using
custom MATLAB scripts following the same preprocessing steps in ImageJ as described
above. For diameter measurements, a scan path was drawn perpendicular to the vessel (see
Figure 2.5) and intensity measurements were taken across a sliding window, but in this
case, the window was 40ms of time, rather than in pixels, and the intensity measurements
were taken from an average of each time window. The sliding window overlaps by 10ms
and the FWHM was calculated from each intensity curve as before.
Red blood cell velocity measurements could be made, as the plasma of injected mice was
fluorescent but the individual RBCs were not, meaning they cast a shadow (see Figure 2.5).
By defining a scan path that travelled along the vessel (see Figure 2.5, left panel), the
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velocity of the shadows (i.e. RBCs) could be measured by calculating the gradient of the
shadow in the outputted image. The flatter the shadow, the faster the RBC velocity as
it has moved further along the scan path in the time it takes the laser to traverse the
path once. To calculate this angle and the velocity, freely available MATLAB code was
adapted (Drew et al., 2010a) and the data was split into overlapping time windows of 40ms
as described for diameter measurements. The method from Drew et al. (2010a) utilised a
radon transform to calculate the average angle of the dark streaks across each 40ms time
window, and the tangent of this angle is inversely proportional to the RBCV, allowing for
a continuous velocity-time trace to be calculated.
Figure 2.5: Example line scan path Left panel: Capillary with streaks of fluorescent plasma
labelled with FITC-dextran (green) and red blood cells(black). A scan path was drawn perpendic-
ular to the vessel axis (grey) to measure diameter and along the vessel (yellow) to measure RBCV.
Right panel: Image collected in SciScan. Each row represents one traversal of the entire scan path
with left section (yellow) depicting the path that travels along the vessel measuring RBCV, and
the right section (grey) depicting the section of the scan path path that is perpendicular to the
vessel and measures diameter.
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Linsecan data processing
Due to the noise present in line scan data, as a result of movement artefacts and the
small pixel size, all traces underwent a number of processing steps to minimise this noise.
Red blood cell velocity traces underwent three preprocessing steps, firstly, when the
angles of RBCs were outputted from the radon transform, angles that were either very
large or very small were removed (see Figure 2.6, Step Two), secondly, once converted
to velocity, the traces then underwent two iterations of outlier removal so that any
points that were greater than three standard deviations above or below the mean of
the trace were removed (see Figure 2.6, Steps Three and Four). Line scan diameter
traces were less subject to noise and so underwent only the first iteration of outlier removal.
GCaMP signal fluorescence
Mice with a genetically encoded calcium indicator in neurons, such as the thy1-GCaMP6f
mice used in this study, have neurons that will change fluorescence as a result of calcium
transients (Dana et al., 2014), so by measuring the changes in fluorescence, it is possible
to measure neuronal activity. An automated region of interest (ROI) finder, suite2P
(Pachitariu et al., 2016), was used to register neuronal recordings, identify ROIs, extract
fluorescence traces and remove background signal. ROIs were selected based upon the
behaviour of the pixels as well as morphological features such as size (see Figure 2.7 for
example ROIs). All pixels in each ROI were connected and did not overlap with any
other ROIs. Within the suite2P graphical user interface (GUI), ROIs could be selected
or deselected by the user and a round doughnut around each ROI provided a background
measure. The fluorescence signal was then extracted from each ROI and at this point (0.7
x the background trace) was subtracted from each ROI to remove any light artefacts, based
on the recommendation from the authors of the suite2P package (Pachitariu et al., 2016).
Where appropriate, the fluorescence signal was normalised to give a ∆F/F measurement









































































































































































Figure 2.7: Automated ROI finder, suite2P An representative image obtained using two-
photon microscopy, maximally projected to show fluorescent neurons. Coloured ROIs denote cells
detected by Suite2P.
Net haemodynamic parameters
Traces for each of the haemodynamic parameters outlined previously were collected by
VMS4.0 (Moor Instruments) at 40Hz. Traces were then exported and loaded directly into
MATLAB as a 2D matrix.
Area Under Curve Measurements
Where appropriate, data were analysed to determine the area under the curve (AUC)
during visual stimulation. This was calculated using the inbuilt MATLAB function “trapz”
which utilised trapezoidal numerical integration.
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2.5 Ex Vivo Experiments
As well as in vivo studies, a small number of ex vivo studies were also carried out us-
ing brain slices. Fixed slices were used to characterise vascular anatomy and levels of
inflammation and detailed experimental procedures are outlined in chapter 3.
2.6 Behavioural Testing
Behavioural tests were conducted by Laura Bell on mice that had undergone surgery. Tests
were conducted over three consecutive days and care was taken to maintain consistency
across the three days. Mice were placed in the same position in the same experimental
box at the same time each day and cages were not cleaned throughout the three day
period. On day one, mice were placed in an empty experimental arena for 10 minutes in
order to become familiar with the environment. A measure of locomotion was obtained
from recordings made on day one, where a 3x3 grid was placed over the arena and the
number of times the mouse crossed a grid line was recorded. The following day, animals
underwent a spatial object recognition task where a pair of objects was placed in the
arena. After 10 minutes of exploring the environment, mice were returned to the home
cage for 5 minutes, before returning to the arena, where one of the objects was moved to
a novel position. Animals were then permitted to explore this environment for a further
10 minutes before being returned to the home cage. On day three, mice were again placed
in the arena with the same pair of objects for 10 minutes with a 5 minute return to the
home cage, however instead of the object being moved to a novel position, it was replaced
by a novel object in the same position (see figure 2.8). This combination of tests helped
to examine spatial and short term memory as mice were expected to spend more time
with the novel object/at the novel position than with the familiar object/position. The
amount of time mice spent interacting with each object was hand scored using a macro in
Excel (Microsoft). Interaction was classed as sniffing, touching or rearing up at an object.
A ratio of time spent exploring the novel versus familiar object/position was calculated
(discrimination ratio) and any animals that spent less than 15 seconds exploring were
excluded from further analysis.
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Figure 2.8: Behavioural Assays On both days mice were free to explore the arena for 10 minutes.
Day 2: Familiar object was moved to a novel location. Day 3: Novel object was placed in a familiar
location.
2.7 Statistical Analysis
Linear mixed models were carried out as described in the text in R, ANOVAs in SPSS
and all other analyses in GraphPad Prism 8. Detailed statistical output and group sizes
for each graph can be found in Appendix A .
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Chapter 3




Animal models expressing human APOE have been reported to have reduced CBF, in-
creased BBB permeability as well as pericyte and endothelial damage and human carriers
display altered CBF many years before going on to develop AD (Bell et al., 2012; Ko-
izumi et al., 2018; Tai et al., 2016). This evidence points towards vascular disruption
associated with ApoE4, however little is known about the ability of carriers to elicit the
neurovascular coupling response and therefore provide neurons with adequate energy sup-
ply. Impairments to this process could help to explain how APOE4 helps to promote the
development of Alzheimer’s disease, as hypoxic conditions have been shown to facilitate
the aggregation of of beta amyloid and tau (Fang et al., 2010; Sun et al., 2006). To study
whether ApoE4 does alter this ability of the vasculature to meet neuronal demand with
adequate blood supply, I first investigated neurovascular function at rest in this chapter,
before going on to study how the neurons and vasculature in APOE4 mice respond to
visual stimulation (in Chapter 4).
The motivation behind the work in this chapter was two-fold. Firstly by examining the
vascular anatomy, resting state neuronal characteristics and intrinsic vascular properties
such as vasomotion, it was possible to garner enough information to determine if APOE4
mice were likely to be operating with a baseline neurovascular deficit. Examining these
basal properties is important before going on to examine the ability of the NVU to elicit
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functional hyperaemia responses in the next chapter. Secondly, by choosing a relatively
young age point, this study helps to further understand the role of ApoE early in the
disease process.
3.1.1 Resting state vascular deficits in AD
As discussed in detail in the main introduction, in those with Alzheimer’s disease, and
in various mouse models of AD, there have been reported alterations to the vasculature
that are thought to have functional ramifications. Such alterations include loss of BBB
integrity (Sweeney et al., 2019; Montagne et al., 2017), an increase in the number of string
vessels (Brown, 2010), capillary constriction (Nortley et al., 2019), pericyte dysfunction
(Sagare et al., 2013) as well as a number of functional studies showing an increase in ca-
pillary stalling (Cruz Hernández et al., 2019) and hypoperfusion (Love and Miners, 2016).
These findings suggest that in AD, there is an impairment in the basal vascular func-
tion, that would likely be compounded when neurons become active and the vasculature
is tasked with providing them with an influx of fresh blood. As well as studies carried
out in AD mouse models, some work has been done to investigate the effect of ApoE4 on
the neurovasculature. Although this work is limited compared to that carried out in AD
models, similar findings have been reported in APOE4 mice, including a more permeable
BBB (Bell et al., 2012; Halliday et al., 2016), a reduction in vascular density (Koizumi
et al., 2018), endothelial and pericyte damage (Bell et al., 2012; Halliday et al., 2016) and
hypoperfusion (Koizumi et al., 2018).
I investigated several of these features of the vasculature in young APOE4-TR mice, in
order to determine the baseline state of vascular function, upon which the functional hy-
peraemia response would be added.
In addition to the vasculature, I assessed the neuronal activity in these mice, whilst at
rest in the dark, allowing for an estimation of energy demand at baseline. It also began
to answer the question of whether or not these young mice displayed any neuronal hy-
peractivity or seizure like activity (Hunter et al., 2012; Nuriel et al., 2017), as previously
reported in older APOE4-TR mice.
3.1.2 Vasomotion
One property of the vasculature that was only briefly eluded to in the main introductory
text, is vasomotion. This is the oscillation of the vascular diameter at a frequency of
∼0.1Hz in arterioles and arteries (Auer and Gallhofer, 1981; Mayhew et al., 1996; Mateo
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et al., 2017). Little is known about the specific drivers of this oscillatory behaviour. Several
studies have reported it to be an intrinsic vascular property that occurs in the absence of
neuronal input (Osol and Halpern, 1988; Gustafsson et al., 1994) or is minimally affected
by large reductions in neuronal activity (Winder et al., 2017) , however others have shown,
by optogenetically driving the envelope over γ band activity, they were able to drive these
slow oscillations in vascular diameter, demonstrating that γ activity entrains vasomotion
(Mateo et al., 2017). These two apparently opposing conclusions can be reconciled by
the idea that, probably, vasomotion is indeed an intrinsic property of vessels that can be
modulated by a number of other inputs, including neuronal activity. What is known, is
that the fluctuation in vascular diameter occurs as a result of the hyperpolarisation and
depolarisation of VSMCs (Gokina et al., 1996; Oishi et al., 2002), resulting in vascular
dilation and constriction respectively. As previously discussed (section 1.1.2), VSMCs are
coupled to endothelial cells via myoendothelial gap junctions, allowing for this electrical
activity to be propagated along the vessel across reasonably long distances (∼1mm) and it
may also be conducted by callosal projections (Mateo et al., 2017). This intrinsic nature of
vessels to fluctuate, independently of neural input, has important implications for resting
state fMRI studies, however that is beyond the scope if this body of work.
Vasomotion is thought to play a role in several brain processes. Firstly, it is important for
the passive clearance of substances, such as Aβ, from the brain. Studies have shown that
a decrease in arteriole pulsatility correlates with a decrease in the movement and clearance
of substances along the vessels (Iliff et al., 2013; van Veluw et al., 2019). It is thought to
play a role in tissue perfusion (Rücker et al., 2000) and oxygenation (Tsai and Intaglietta,
1989). Its involvement in these multiple processes means that vasomotion can also serve
as a useful indicator of whether the vasculature is functioning properly.
In Alzheimer’s disease, several studies suggest that aberrant vasomotion may be part of
the disease pathology. van Veluw et al. (2019) showed that disruption to the VSMCs as a
result of Aβ, meant that vessels were less able to be driven to oscillate at the vasomotion
frequency and the clearance of dextran from the parenchyma was reduced accordingly. In
addition, other studies have shown that dysregulation of neuronal Ca2+, as a result of
Aβ, can cause a disruption to the vascular tone (Di Marco et al., 2015). Other effects of
Aβ on the vasculature can cause the release of ET-1 which is a vasoconstrictor (Nortley
et al., 2019; Palmer et al., 2012) and the suppression the production of the vasodilator
NO (Toda and Okamura, 2012). Paradoxically, the suppression of NO has been shown
to enhance vasomotion (Dirnagl et al., 1993; Yuill et al., 2010) however in tandem with
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the effects of ET-1, aberrant fluctuations could occur that are outside of the optimal
vasomotion frequency range. Evidently, disruption of vasomotion could have multiple
deleterious effects in AD, and its role in the disease process is important to consider.
What is unknown however, is whether vascular interactions with ApoE can impact this
process, and if they do so in an isoform dependent manner.
3.1.3 Aims
The aims of this chapter were to validate the 3-4 month age range as a suitable,
pre-clinical time point and subsequently to understand how the baseline vascular
properties might be altered in APOE4 mice. Specifically, it aimed to determine :
1) Are there deficits to the vascular anatomy and functionality in
APOE4 mice, even in the absence of neuronal demand? As aforemen-
tioned, gaining this knowledge will help to further the understanding of ApoE4
on the neurovasculature so a basal energy balance in the brain can be estimated.
2) Is neuronal activity in the absence of a sensory stimulus altered in these
animals? Any vascular alterations could be a response to altered energy demands, to




3.2.1 In Vivo Preparation
3.2.2 Data Collection
As previously explained in the main methods section, APOE3-TR and APOE4-TR an-
imals that had undergone cranial window surgery were either imaged using two-photon
microscopy or had net haemodynamic parameters recorded across the window using the
OXY-CBF probe. Pial and capillary diameter measurements, capillary RBC velocity
measurements and population neuronal activity was recorded and for all of these para-
meters, with the exception of the capillary recordings, dedicated “baseline” recordings
were taken where visual stimuli were not presented. On average, recordings lasted for ∼4
minutes. Locomotion was recorded using a rotary encoder device.
Data analysis
Baseline vascular and haemodynamic measurements
Data was extracted as described in section 2.4.2 and rest epochs in each of these meas-
urements were identified, i.e. periods when the mouse was not moving. For capillary
diameter and RBC velocity traces, where there was also a visual stimulation, rest periods
were selected only during the inter-stimulus interval, when there was no visual stimulation
displayed.
Movement of any duration was classified as locomotion and was removed from the analysis
along with a 1.5 second transition period on either side. Any epochs that were within 3
seconds of each other were classified as the same event and so the entire period was re-
moved.
The remaining data was averaged together to provide average pial and capillary diameters
and average RBC velocities per blood vessel and average net CMRO2, SO2 and flux per
animal. The coefficient of variation was calculated for RBCV, SO2 and flux measurements
by dividing the standard deviation by the mean.
In vivo z-stacks were taken along the horizontal plane, as deep into the parenchyma as was




Rest epochs of at least 10 seconds were detected as described above, and the corresponding
pial and capillary diameter traces during these epochs were taken for further analysis. A
fast Fourier transform (FFT) of vessel diameter was carried out for each epoch using
the inbuilt MATLAB “FFT” function. The variation in epoch length and the subsequent
effect on the power, was controlled for by dividing by length. To produce an average power
spectrum for each vessel, non-linear interpolation was used to make all FFTs the median
length of all rest epochs per vessel. To control for pink noise (Szendro et al., 2001) all
traces were multiplied by the frequency, and to control for variations in the power arising
from variations in vessel brightness, relative power was determined by dividing all traces
by their sum.
Neuronal Data
Fluorescence traces were extracted from neuronal recordings, as previously described in
section 2.4.2, and the number of peaks per minute during rest periods were detected.
Rest epochs of a least 10 seconds were detected as outlined above and the corresponding
fluorescence traces were stitched together. Peaks that were at least twice the standard
deviation of the entire trace and were at least 0.25 seconds apart from each other were
counted and converted into peaks per minute. The trace was normalised to the middle
1000 frames (∼2minutes) to give a ∆F/F trace and the size of each peak was determined.
3.2.3 Slice Preparation
Tissue Extraction
With the assistance of Dr Kira Shaw, NG2-DsRed positive animals were transcardially
perfused with a fixative and a fluorescent gel to enable visualisation of the vasculature
post-mortem (Lugo-Hernandez et al., 2017; Tsai et al., 2009b). Animals were injected
intraperitoneally with pentobarbital which acted as a terminal anaesthesia. Once the
animal was no longer responsive to a toe pinch and had no other reflexes, the chest cavity
was opened and the heart exposed. A 25 gauge needle was inserted into the left ventricle
and the right atrium cut to allow for blood drainage. Iced 0.1M phosphate buffer saline
(PBS) was then perfused into the heart for 5 minutes at 5mL/min followed by 15 minutes
of iced 4% paraformaldehyde (PFA - Sigma-Aldrich) in PBS to fix the tissue. This was
followed by 5 minutes of PBS warmed in a water bath to 30 ◦C , and finally by 3 minutes of
5% gelatin (Sigma-Aldrich) containing 0.2% FITC-conjugated albumin (Sigma-Aldrich).
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Animals were then kept on ice for a minimum of 30 minutes before the brain tissue was
extracted and placed into 4% PFA for 24 hours at 4◦C, after which it was transferred to
30% sucrose in PBS for a minimum of 3 days.
For tissue that underwent immunofluorescent staining, tissue was extracted fresh and
placed directly into PFA, as animals were being imaged under terminal anaesthesia and
therefore, transcardial perfusion was not possible. Tissue was stored overnight in 4% PFA
at 4◦C before being transferred to 30% sucrose in PBS for a minimum of 3 days.
For both experiments, brains were coronally sliced to 200µm on a vibratome (Vibratome®)
and those slices containing the visual cortex (as per the Allen Brain Atlas) were selected
and were either stained for microglia and astrocytes before mounting or else directly
mounted onto slides (SuperFrost, Thermo Scientific) and covered with HardSet Vectashield
(Vector Labaratories) and glass coverslips (Menzel 24 x 60 mm 0.13 - 0.16mm, Thermo
Scientific).
Immunofluorescence Protocol
The immunofluorescence experiments and image capture was carried out by Laura Bell
using the method outlined below.
All incubation and washing steps were done under gentle agitation of the slices on a
shaker. Upon slicing, brain tissue was washed for 10 minutes in PBS, three times before
being incubated in a blocking/permeabilisation solution (5% normal goat serum (Sigma-
Aldrich), 0.3% Triton X-100 (Sigma-Aldrich) in PBS) for a minimum of 1 hour. Slices
were then incubated in primary antibody for 36 hours at 4◦C and washed in PBS, three
times for 10 minutes. They were then incubated in secondary antibody for 24 hours at
4◦C before being washed in PBS, three times for 10 minutes. Slices were then mounted
as described above. See table 3.1 for antibody details.
Immunofluorescence Imaging
The primary visual cortex regions of slices were imaged using an inverted Leica SP8
TCS confocal microscope (Leica Microsystems) using a 20x air objective (HC PL APO
CS2 20X/0.75, Leica Microsystems). Continuous wave lasers with excitation wavelengths
of 488nm, 561nm and 633nm were used to visualise FITC, DsRed and AlexaFluor 647,
respectively. Z-stack images were collected as a 1024 x 1024 pixel matrix, with a line
average ranging between 3 - 4, a lateral pixel resolution ranging from0.45µm - 0.57µm,
and a z-pixel depth ranging from 0.7µm -2.4µm. All imaging was carried out with the user
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Table 3.1: Antibody details
blinded to animal genotype. Images were viewed and analysed using ImageJ (Schindelin
et al., 2012). NG2-DsRed/APOE-TR mice were used throughout all experiments. In those
used to characterise vascular anatomy, DsRed was used to mark pericyte locations and
calculate the number of pericytes per mm of vessel, and the vasculature filled with the
FITC-conjugated albumin was used to assess vascular morphology. To study the effect of
cranial window surgery on the inflammatory markers microglia and astrocytes, slices were
stained for Iba1 and GFAP respectively.
Image Analysis
To characterise the vasculature and pericytes, z-stacks were analysed in ImageJ using a
macro built by Dr. Devin Clarke. Both in vivo stacks and slice stacks were analysed in this
way. First, stacks were registered and averaged across imaging planes, any large patches
of noise were manually selected and removed, before thresholding using the autothreshold
function in ImageJ. In one case the stack was manually thresholded but otherwise the
Default, Huang, Huang2 or Li thresholds were selected, based upon which one best rep-
resented the non-thresholded stack. The vasculature was then skeletonised in 3D, all
skeleton co-ordinates and branch points were determined and a distance map created of
the vasculature. Vessel length was then calculated from the branch skeletons, density was
determined from these values and vessel radii were found by determining the grey value
from the distance map at each skeleton point. Pericyte cell body locations were marked
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using the imageJ multipoint tool and vessel diameter as function of distance from the cell
body was computed. Vessel tortuosity was calculated by dividing branch length by the
euclidean length. All values were averaged per slice.
Microglia and astrocytes were analysed by Harry Trewhitt by conducting cell counts in
35µm bins from the surface of the brain on the surgical and non-surgical hemispheres.
The cell counts were normalised to the area of each bin and the surgical hemisphere was
normalised to the non-surgical hemisphere.
3.2.4 Behavioural Testing
All behavioural testing and analyses were carried out as described in section 2.6.
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3.3 Results
3.3.1 Effect of ApoE on spatial and short term memory
To test whether 3-4 month old animals exhibited cognitive deficits, three simple behavi-
oural measures were obtained. To test short term memory (Clark et al., 2000), a novel
object recognition task was carried out and similarly, a spatial object recognition task was
carried out to assess hippocampal dependent spatial memory (Dix and Aggleton, 1999).
As the hippocampus is especially vulnerable in AD, this task was of particular interest
and is where any deficits might have been expected to be observed. A discrimination
ratio (DR) was calculated for both, with a higher DR indicative of better short term /
spatial memory. Finally, a measure of locomotion was obtained to asses how much the
mice moved within the testing arena. Across all three behavioural measures, APOE3 and
APOE4 mice displayed similar DRs (see figures 3.1A, B) and similar measures of loco-
motion (see figure 3.1C) suggesting that there were no impairments in the short term or
spatial memory of APOE4 mice of this age. This is an important finding as young animals
were chosen to study the interaction of ApoE and the vasculature, prior to any cognitive
deficits and the findings of these tests confirm the suitability of this age point.
Figure 3.1: Effect of ApoE on spatial and short term memory A. Discrimination ratios
for APOE3 and APOE4 mice during a novel object recognition task. B. Discrimination ratios for
APOE3 and APOE4 mice during a spatial object recognition task. C. A measure of locomotion for
APOE3 and APOE4 mice. Circles represent individual animal scores. Error bars represent SEM.
For statistical outputs and n numbers see table A.1
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3.3.2 Inflammation at the surgical site
ApoE4 has previously been associated with elevated inflammatory responses as a result of
increased cytokine release (Fan et al., 2017; Ophir et al., 2005) and microglial activation
(Safieh et al., 2019; Rodriguez et al., 2014). Although, in this study, every effort was
taken to ensure mice were given sufficient time to recover from surgery (with a minimum
recovery period of 2 weeks), it was still essential to ensure that neither genotype was
disproportionally affected by the surgery, and therefore have the confounding effect of
inflammation present. Sliced tissue was stained for microglia and astrocytes (figure 3.2A),
as markers of inflammation. The number of cells as a function of distance from the surface
of the brain was quantified from the surgical site and normalised to the non-surgical
hemisphere. Results show that the normalised cell numbers did not differ over distance
and at the surface of the brain, APOE4 animals did not show an increase in inflammatory
markers (figures 3.2B, C). These data suggest that there were not increased levels of
inflammation in APOE4 mice following recovery from the cranial window implantation.
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Figure 3.2: Effect of ApoE on inflammatory responses post surgery A. Example images
of Iba1 positive cells (microglia) and GFAP positive cells (astrocytes) in brain slices. Taken using
confocal microscopy. B. Number of GFAP positive cells in each distance bin (from the surface
of the brain). Surgical hemisphere was normalised to non-surgical hemisphere. C. Number of
Iba1 positive cells in each distance bin (from the surface of the brain). Surgical hemisphere was
normalised to non-surgical hemisphere. Circles represent slice average at each distance point. p
values reflect difference in the slopes. For detailed statistical output see table A.2.
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3.3.3 Effect of ApoE on Vascular Anatomy
To characterise the vasculature in APOE3 and APOE4 mice, various parameters were
measured across several platforms. These parameters included capillary density as an
indicator of how well perfused the parenchyma was, capillary diameter as an indicator
of blood volume that can reach the tissue, as well vascular tortuosity. Vessel tortuosity
has previously been reported in AD where vessels have become twisted or kinked. This
could result in a disruption to the network as a result of increased vascular resistance
(Govindpani et al., 2019). Initially, these measures were obtained from in vivo z-stacks
taken using two-photon microscopy (see figure 3.3A for an example image). No genotype
differences were observed in the capillary density, diameter or tortuosity (figure 3.3B, C,
D).
Whilst the in vivo approach was an attractive option as it measured from living tissue
and was therefore not subject to post-mortem modifications and processing, the fact that
the images were taken on a horizontal plane made it more difficult to gain information on
the smaller capillaries that were deeper and therefore less bright. In addition, the imaging
parameters used resulted in a relatively large pixel size (1.28 µm) making it difficult to
pick out finer structures. This is evident from the observed average capillary diameter of
∼6µm which is larger than has previously previously reported (Koizumi et al., 2018).
56
Figure 3.3: In vivo vascular anatomy A) An example horizontal z-stack taken from an APOE3
animal, using two-photon microscopy. Scale bar (white) = 100µm. B. In vivo capillary density in
APOE3 and APOE4 mice. C. Average in vivo capillary diameter (left panel). Relative frequency
distribution of all vessel diameters (right panel) D. Average in vivo capillary tortuosity (left panel).
Relative frequency distribution of all vessel tortuosity measures (right panel). Circles represent
individual animal averages. Error bars represent SEM. For detailed statistical output see table A.3
57
To overcome these difficulties in measuring from the smallest capillaries that were deep
within the tissue, fixed coronal brain slices were taken from APOE3 and APOE4 anim-
als and imaged using confocal microscopy. Animals had the vascular lumen filled with
a fluorescent gel, allowing for the visualisation of the vascular network and the presence
of DsRed in pericytes allowed for the examination and quantification of pericyte number.
As is evident from figure 3.4A, this method allowed for easier visualisation of the smallest
vessels, as well as for a smaller pixel size (0.57µm) than the in vivo images. This improved
ability is also reflected in the lower capillary diameters measured across both genotypes
(figure 3.4F, G) that better reflect the known range of capillary diameters (Koizumi et al.,
2018; Shaw et al., 2019). Although with this method it is possible that some capillaries
could have collapsed post mortem or were incompletely filled with gel.
These data from fixed tissue provided some interesting findings. In APOE4 animals the ca-
pillary density was reduced compared to APOE3 animals (figure 3.4B) which concurs with
previous reports (Koizumi et al., 2018). Vessel tortuosity remained unchanged between
genotypes (figure 3.4D), as did the number of pericytes per mm of vessel (figure 3.4C).
Another intriguing difference between these data and the vivo recordings, was that the
average capillary diameter in APOE4 mice, was greater than that in APOE3 mice. This
has not previously been reported and was unexpected.
To further investigate this, capillary diameter as a function of distance from the pericyte
soma, was calculated following findings by the Attwell group (Hall et al., 2014; Nortley
et al., 2019) showing that pericytes can cause pathologic constriction in capillaries in
response to ischaemia or Aβ. When considering the actual diameters along the vessel, it
was apparent that the diameter at the soma was larger in APOE4 than in APOE3 mice
(figure 3.4G, H), as found for the overall average diameters. However, normalising each
vessel’s diameter to that at the pericyte soma revealed that the diameter of APOE4 vessels
increased with distance from the soma (the slope of the diameter as a function of distance
from the soma was significantly different from zero), while APOE3 vessels had the same
tone regardless of distance from the pericyte soma (figure 3.4I). These results suggest
that there may be some dysfunction at the pericyte processes, resulting in the inability to
maintain vascular tone. Important to note, is that these experiments show data from a
relatively small experiential group (n = 3/4 animals per genotype) and replicates would
be required to ensure these findings were sound.
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Figure 3.4: Slice vascular anatomy A. Example z-projection of a brain slice from an APOE3
animal with FITC-conjugated albumin (green) filled vasculature and DsRed positive pericytes and
SMCs (red) taken using confocal microscopy. B. Capillary density measurements from APOE3
and APOE4 mice. C. Number of pericytes per mm of vasculature in APOE3 and APOE4 mice.
D. Vessel tortuosity (branch length/euclidean length) from APOE3 and APOE4 mice. E. Average
capillary diameter from APOE3 and APOE4 mice. F. Relative frequency distributions of all vas-
cular diameters. G. Average capillary diameter at the pericyte soma in APOE3 and APOE4 mice.
H. Absolute capillary diameter as a function of distance from the pericyte soma. I. Normalised
capillary diameter as a function of distance from the pericyte soma. All circles represent a slice
average and error bars represent SEM. For detailed statistical output and group sizes see table A.4
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Individual vessels were sampled to further determine if there were any functional, as well
as anatomical differences between genotypes. At an individual vessel level, the pial and
capillary diameters did not differ between genotypes (figures 3.5A, B), nor did capillary
RBC velocities (figures 3.5C). Some capillary diameters recorded in mice of both geno-
types were smaller than expected (i.e. a minimum value of 1.7µm, as opposed to ∼3µm
as seen in other studies (Koizumi et al., 2018; Shaw et al., 2019)). This is likely because
of the passage of RBCs creating dark patches in the vessel and so decreasing the average
diameter - it is therefore likely that the diameters obtained from the slice preparation were
more accurate.
Resting net values across the visual cortex were compared between genotypes. It might
have been expected to observe lower CBF (flux) or SO2 values, as a result of the lower
vascular density, however there was no genotype difference observed (figures 3.5D, E).
In addition, the oxygen use in the brain (CMRO2) was the same across genotypes (fig-
ure 3.5F).
The coefficient of variation (CV) provides a measure of temporal variability of each para-
meter, for flux and RBCV this measurement gives an indication of how oxygen delivery
may, theoretically, be altered (Lu et al., 2019). Although there were no significant differ-
ences between genotypes across all three measures (figure 3.5G, H, I), there was a trend
towards an increased CV in the RBCV in APOE4 mice (p= 0.09) suggesting that oxygen
delivery may be mildly altered in APOE4 animals.
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Figure 3.5: In vivo resting state measurements A. Average pial diameter during rest periods
in APOE3 and APOE4 mice. B. Average capillary diameter during rest periods in APOE3 and
APOE4 mice. C. Average capillary red blood cell velocity during rest periods in APOE3 and
APOE4 mice. D. Average net flux (E) SO2 and (F) CMRO2 during rest periods in APOE3
and APOE4 mice. Coefficient of variation for net flux (G.) and SO2 (H.) measurements, and
for capillary RBC velocity measurements (I.) For A-C and I, circles represent individual vessel
averages, for D-H circles represent animal averages. Error bars represent SEM. For statistical
outputs see table A.5.
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This examination of the vascular anatomy and functionality at rest, both in vivo and in
slices, suggests that vascular properties were largely preserved in APOE4 mice, with the
exception of the reduced vascular density and a trend suggesting the CV of RBC velocity
might be higher in APOE4 mice. An increase in the CV of RBC velocity is thought to be
reflective of an increased capillary transit time heterogeneity, an increase in which might
suggest some alterations to oxygen extraction (Østergaard et al., 2013). In this case,
these results were not significant and there was no corresponding change in resting SO2,
so it is likely that the trend level results were not having an significant impact on tissue
oxygenation.
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3.3.4 Examining Vasomotion in APOE-TR animals
As vasomotion is an important physiological process when considering clearance, tissue
perfusion and oxygenation, it is an interesting parameter to explore in APOE-TR animals.
Its role in these various processes means it can be useful in probing vascular health and
indeed it has previously been found to be impaired in AD (Di Marco et al., 2015). In
order to detect vasomotion, the time domain of vascular diameter traces during rest (see
figure 3.6A) were converted to the frequency domain using a fast Fourier transform. Util-
ising this method, a peak was indeed observed in the vasomotion frequency range (∼0.1Hz)
(See arrow in figure 3.6B). The power at the vasomotion frequency was determined for all
APOE3 and APOE4 vessels during rest and the power (relative to the sum of the whole
power spectrum) was determined across frequency bins of 0.1Hz. The relative power was
found to be greater in APOE3 animals from 0.1-0.3Hz, with the 0.3- 0.4 Hz range almost
reaching statistical significance (p = 0.051, figure 3.6C). When directly comparing the re-
lative power at 0.1Hz, APOE3 mice exhibited statistically higher power at this frequency
(figure 3.6D). As a further verification that power in the 0.1- 0.3Hz reflected vasomotion
and not something else, I compared the power at the same frequencies in capillaries which
do not exhibit vasomotion (Mateo et al., 2017; Di Marco et al., 2015). As can be seen in
figure 3.6E, there was no peak at the vasomotion frequency, nor were there any differences
in the relative power from 0.1Hz - 0.4Hz (figure 3.6E, F), confirming that the frequency
bump observed in the pial diameter traces was not due to noise created during the FFT.
These data point towards an intrinsic deficit within the APOE4 vasculature with pos-
sible consequences to the clearance and perfusion mechanisms in these animals, although
further experiments would be needed to confirm the functional implications.
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Figure 3.6: Vasomotion during rest A. An example diameter (top panel) and the corresponding
locomotion (bottom panel) trace. Detected rest periods are represented by the green bars. B.
Relative power spectrum of the vessel shown in A. Arrow denotes the peak in the vasomotion
frequency range. C. Relative power spectra for all averaged APOE3 and APOE4 pial vessels.
Upper right insert corresponds with the grey dashed box. Dashed grey lines on insert graph show
the frequency bins that were compared. D. Relative power at 0.1Hz for APOE3 and APOE4 pial
vessels. E. Relative power spectra for all averaged APOE3 and APOE4 capillaries. Upper right
insert corresponds with the grey dashed box. Dashed grey lines on insert graph show frequency
bins that were compared. F. Relative power at 0.1Hz for APOE3 and APOE4 capillaries. Circles
represent vessel averages. Error bars represent SEM. For statistical outputs see table A.6.
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3.3.5 Resting Neuronal Activity
In order to relate any vascular activity to neuronal demand, two-photon microscopy
was used to examine the characteristics of fluorescent excitatory neurons. The number
of peaks per minute has previously been used as an indicator of neuronal hyper- and
hypoactivity (Busche et al., 2019) . Peaks were detected in the fluorescence traces
(see figure 3.7A) and when averaged across animals, there was no observed difference
between genotypes (see figure 3.7B). The correlation of neuronal firing was measured to
determine if there were greater mass increases in neuronal activity in either genotype.
The correlation coefficients that were measured were small, as to be expected when
measuring sporadic firing in the absence of a stimulus. There was no difference in the
average correlation of firing between genotypes (figure 3.7C), suggesting that the activity
was equally “sporadic”. Finally, the magnitude of detected peaks was determined. The
amount of firing is tightly correlated to the magnitude of the GCaMP signal (Akerboom
et al., 2012) and so is a useful measurement to gauge the amount of neuronal activity
occurring. As with the other neuronal characteristics, there was no observed difference
between genotypes (figure 3.7D). All data was averaged both by animal (as shown in
figure 3.7) and across all cells. Data averaged across all cells (see figure B.1) showed the
same pattern of results as seen in animal averages.
These data suggest that the neuronal characteristics were similar between geno-
types and the basal energy requirements would therefore also be similar. This, coupled
with the findings that the tissue in APOE4 mice had a less dense vascular network, less
vasomotion and possibly a slight increase in temporal variability, suggests that there may
be an energy imbalance in the tissue of APOE4 mice. However, this possible imbalance
was not sufficient to alter resting SO2 levels and is therefore likely to be subtle.
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Figure 3.7: Neuronal activity during restA. Example ∆F/F trace with detected peaks marked
with purple circles. B. Average peaks per minute. C. Averaged correlation coefficient per animal.
D. Average peak size per animal in APOE3 and APOE4 mice. Circles represent detected peaks
(A) or individual animal averages (B, C, D). Error bars represent SEM. For detailed statistical
output and n numbers see table A.7.
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3.3.6 The Effect of ApoE4 and Sex on resting Neurovascular Parameters
Previous reports have suggested that female APOE4 carriers are more vulnerable to the
pathological effects of the ε4 allele (Farrer, 1997) although it has been suggested by others
that the risk of developing AD in APOE4 carriers is equal between males and females
(Neu et al., 2017). Therefore, I wished to determine if there were any effects of sex on
the data presented. For all the parameters analysed in figure 3.8, the effects of sex and
genotype, as well as the sex*genotype interaction were elucidated. Across all parameters,
bar neuronal PPM, there was no effect of sex, nor was there an interaction between sex
and genotype in any of the measurements. In neuronal PPM measurements, there was an
effect of sex, with females having a higher number of PPMs compared to males. These
data indicate that sex does not have a robust effect on the results presented in this chapter
and so grouping together both sexes was appropriate.
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Figure 3.8: Effect of sex on vascular and neuronal parameters A.Relative power of pial
diameter traces at 0.1Hz (vasomotion frequency), split by sex. B. Resting pial diameter, split
by sex. C. Resting capillary diameter, split by sex. D. Resting capillary RBC velocity, split by
sex. E. Neuronal peaks per minute during rest periods, split by sex. Net flux (F), SO2 (G)
and CMRO2(H) , split by sex. A-D violin plots represent average values per vessel, E represents
average value per cell and F-H represent average values per animals. Error bars represent SEM.
For detailed statistical output and n numbers see table A.8.
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3.4 Discussion
3.4.1 Results Summary and Interpretation
Young APOE4 animals do not display behavioural deficits
The insidious nature of AD, involving a prolonged pre-clinical period during which many
pathophysiological events occur, means that the early stages of the disease are of great
interest. Work from Iturria-Medina et al. (2016) has shown that vascular effects are
one of the earliest deficits observed in AD patients, this in tandem with APOE4 being
the most common genetic risk factor for going on to develop AD, makes studying the
neurovasculature in young, APOE4 mice, an interesting and valuable research avenue.
Critically, it is important to know more about what happens prior to the onset of cognitive
decline so that a viable therapeutic target can eventually be identified.
In this study, 3-4 month old animals were chosen for several reasons, firstly, work from
Koizumi et al. (2018) suggested that neuronal function was intact in animals of this age,
but that there were already vascular deficits. In addition, practically speaking, to allow
mice at least two weeks to recover, surgery needs to be carried out when mice are aged
∼8-10 weeks. Even at this age, mice (especially females) can be very small, so it would be
difficult to obtain data on animals younger than this. The behavioural assays carried out
in this chapter showed that there was no difference in the short term and hippocampal
dependent spatial memory in young APOE4 animals, confirming this age as a suitable
“young” time point to study. To fully assess cognitive function, a more thorough cognitive
battery would be required, however this is outside of the scope of this work.
APOE4 mice have less perfused tissue but have larger capillary diameters
Although the in vivo approach had multiple advantages over a slice preparation in determ-
ining capillary density and diameter, the imaging parameters used, and the horizontal
nature of the z-stacks made it difficult to collect information on the smallest vessels.
Although one of the advantages of two-photon microscopy is the ability to penetrate re-
latively deep into living tissue (Shih et al., 2012), in this case, coronal slices offered a
far superior look at the entire vascular tree. Therefore the data obtained from FITC-gel
filled sliced was assumed to be more accurate than that obtained from the in vivo stacks.
Congruent with work from Koizumi et al. (2018), APOE4 animals were shown to have
a lower capillary density, when compared to APOE3 animals, suggesting that the tissue
was generally less well perfused. On average neurons are <15µm from the nearest capil-
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lary (Tsai et al., 2009a), allowing for the easy transmission of vasoactive messengers from
neurons to the vessels (either directly or indirectly), as well as the provision of oxygen
and glucose from the blood to these neurons. If these substrates have further to travel it
could result in hypoxic pockets within the parenchyma or inadequate energy supply to the
neurons. Paradoxically, the capillary diameters were larger in APOE4 animals, compared
to APOE3 animals, coupled with this, it was found that the normalised capillary diameter
increased further with increasing distance from the pericyte. There are a number of pos-
sibilities that could be at play, the pericytes could be dysfunctional and failing to maintain
vascular tone - particularly at the processes. Alternatively, it could be a compensatory
mechanism in place to allow a greater volume of blood to be delivered. Importantly these
findings need to be replicated as they have currently been made in slices from a small
number of animals.
APOE4 mice may have a larger degree of capillary RBC velocity heterogeneity
When individual pial and capillary diameters and capillary RBC velocities were
measured during rest periods, they did not significantly differ between genotypes.
Mathematical modelling has suggested that increased heterogeneity in the capillary bed
could result in a lower oxygen extraction from the blood (Østergaard et al., 2013). In this
study, the temporal variability in RBC velocity trended towards being higher in APOE4
animals, suggesting that less oxygen may be being extracted from the vasculature com-
pared to APOE3 mice. As aforementioned, these changes were very small and may not
have had any meaningful impact on the tissue oxygenation as resting SO2 was not different
between genotypes.
In light of the reduced vascular density observed in APOE4 mice, it would have been
expected to detect a reduction in net CBF in these same animals. Unusually this was not
the case, but a close look at the data might provide some insights as to why. APOE4
animals have a ∼18% reduction in vascular density, compared to APOE3 mice. In recent
work from our group comparing the vascular density in the hippocampus and the visual
cortex, there was a ∼47% reduction in vascular density that corresponded with a ∼25%
reduction in net CBF (Shaw et al., 2019). Directly applying these findings to the data in
this chapter, a ∼18% reduction in vascular density might be expected to result in a ∼9%
reduction in CBF. In fact, the net CBF measurements in APOE4 mice were ∼11% lower
that that measured in APOE3 mice, but due to the error present in the data, this was not
significantly different. It is therefore likely that any resultant differences in CBF could
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not be detected within the error of the data.
APOE4 mice exhibit a lower relative power at the vasomotion frequency
In what is, to my knowledge, the first look at vasomotion in APOE4-TR mice, a convincing
reduction in the relative power from 0.1-0.3Hz was observed in APOE4 pial arterioles.
Although vasomotion is classically at 0.1Hz, shifts from this frequency have previously
been reported (van Veluw et al., 2019; Drew et al., 2010b). This fairly broad “peak” is
therefore well within the vasomotion range, and further, the lack of a peak in capillary
trace, buttresses the conclusion that it was vasomotion being observed. As previously
discussed, vasomotion is an important indicator of vascular health as well as being a driver
in clearance and perfusion mechanisms (Di Marco et al., 2015; Iliff et al., 2013; van Veluw
et al., 2019) so this reduction in power is an interesting finding in APOE4 mice. At the
very least it suggests some intrinsic vascular dysfunction at the pial level, and probably
means there will be some disruption to the other, aforementioned, functions. APOE4
carriers already show slower clearance of Aβ due to the slower VLDL clearance pathway
(discussed further in section 1.3), but this reduction in arteriolar pulsatility could be a
additional contributing factor. Further experiments could be carried out to investigate the
paravascular clearance of substances in APOE4 mice, such as monitoring the clearance
of a fluorescent dye post vessel ablation, to determine the wider impact of the reduced
oscillatory behaviour.
Neuronal characteristics are similar between genotypes
Using the number of peaks per minute, the size of these peaks and the correlation of
neuronal firing, it was demonstrated that excitatory neuronal characteristics at rest and
in the absence of visual stimulation, did not differ between genotypes. It was suggested
by previous work that this would be the case in mice of this age and confirms that the
observed vascular deficits in these baseline parameters are not as a result of reduced
neuronal demand.
3.4.2 General Discussion
The overarching aim of this chapter was to determine if there were vascular deficits in
APOE4 mice, even in the absence of a sensory stimulus. This allowed for an evaluation of
how the NVU was operating at baseline and so when, in the following chapter, functional
hyperaemia is investigated, it is known upon what baseline any deficits occur. The data
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presented in this chapter demonstrate that, although subtle, there are several signs that
the vasculature was impaired in APOE4 mice. Firstly, the tissue was less well perfused
as a result of a less dense capillary bed, this could result in hypoxic brain tissue over
time, which has been shown to have a role in the accumulation of Aβ and tau in AD
(Fang et al., 2010; Sun et al., 2006). Compounding this effect, is the apparent increase in
heterogeneity of flow within the blood vessels which is thought to reflect altered oxygen
extraction from the blood to the parenchyma (Østergaard et al., 2013). As well at this, the
reduced vasomotion signal in APOE4 mice is indicative of intrinsic vascular dysfunction
and could have other functional consequences on perfusion and oxygenation as discussed
above. What is unclear, is if the observed increase in vascular capillary diameter in APOE4
mice is a sign of pathological pericyte activity, or a compensatory mechanism to achieve
a greater blood volume delivery. Although pericytes have been shown to die in rigour
under pathological circumstances such as ischaemia (Hall et al., 2014), it is also possible
that under certain conditions, such as inflammatory damage from the upregulation of the
CypA-NF-κB-MMP9 pathway in APOE4 pericytes (Bell et al., 2012), contractile vascular
tone might be lost (Mishra et al., 2014; Hartmann et al., 2020).
Either way, it is clear that there is some degree of vascular perturbation in these young
animals, even in the absence of a stimulus. However, importantly, the dysfunction present
in APOE4 animals was insufficient to alter resting net measurements and so is likely to
be very subtle. It would be pertinent to study the consequence of these effects on the
tissue, most notably to determine if hypoxic regions do exist using hypoxprobe staining
(Aguilera and Brekken, 2014) or phosphorescence lifetime imaging (Sakadžić et al., 2010).
Immunohistochemical staining for hypoxia markers (Aguilera and Brekken, 2014) has pre-
viously shown that there was indeed less oxygen in the tissue of 3-4 months APOE4 mice
(Koizumi et al., 2018).
What has not been addressed in this chapter are the mechanisms underlying these defi-
cits. Whether they are developmental or not is unknown, but various cells that make up
the neurovascular unit have been found to be damaged as a result of ApoE4, including
pericytes, endothelial cells and basement membrane (Montagne et al., 2020; Bell et al.,
2012; Halliday et al., 2016), a reduction in the angiogenic factor, VEGF, has been re-
ported (Salomon-Zimri et al., 2016), and in an APP mouse model, a disruption to SMC
integrity was shown in relation to a reduction in vasomotion (van Veluw et al., 2019). In
a study from Koizumi et al. (2018), it was suggested that ROS could be causing vascular
disruption in APOE4-TR mice, so it is feasible that any, or more likely, a combination of
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several of these factors are at play.
Examining each of these cell types morphologically and functionally, where possible, could
help to untangle some of these effects. For example, the monitoring of calcium levels in
SMCs as well as assessment of the structural integrity would demonstrate if the reduced
vasomotion in APOE4 mice results from aberrant SMC signalling or a disruption to the
structure. Similar experiments could be carried out to examine pericyte function.
.
3.4.3 Conclusion
In this chapter I have shown that the vasculature in young APOE4 animals is vulnerable
to dysfunction, seen as reduced vasomotion, reduced vascular density and increased het-
erogeneity of RBC velocity. Although this did not manifest in alterations in blood SO2, it
is suggestive of subtle early changes to the energy delivery system in these young animals
that could, over time, result in alterations in tissue oxygenation.
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Chapter 4
Effect of ApoE4 on Neurovascular
Coupling in Young Mice
4.1 Introduction
Following the exploration into neurovascular parameters under resting state conditions,
allowing for a balance between baseline energy supply and demand to be estimated, this
chapter investigates how these neurovascular parameters change under stimulus conditions.
Importantly, it will elucidate whether or not the mild deficits observed in APOE4 mice
under resting state conditions, continue to present when the primary visual cortex becomes
active.
Neurovascular coupling is an essential brain function
As previously mentioned, one of the critical functions of the brain’s vasculature is to
provide energetically expensive neurons with oxygen and glucose to enable the generation
of ATP by oxidative phosphorylation and glycolysis. ATP is primarily used to restore
and maintain ions gradients in neurons (Attwell et al., 2010). The process by which the
brain increases local blood supply following synaptic activation, is called neurovascular
coupling and disruptions have been reported in various pathologies, including FTD, ALS,
Parkinson’s Disease and Alzheimer’s Disease (Iadecola, 2017; Zlokovic, 2011; Kisler et al.,
2017a; Sweeney et al., 2018a; Shabir et al., 2018).
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Could perturbations to neurovascular coupling have a role in AD?
Something to note is that the neurovascular response has a considerable spatial spread
(O’Herron et al., 2016), meaning that in some cases, a relatively local demand results
in a widespread increase in net supply, sometimes lyrically described as “watering the
entire garden for the sake of one thirsty flower” (Malonek and Grinvald, 1996). This
leads to the question of whether or not disruptions to this system would have deleterious
pathophysiological effects and could therefore play a role in AD.
As discussed extensively in chapter 1, evidence suggests that early perturbations to the
vasculature are indeed of great importance in the disease progression (Iadecola, 2017;
Zlokovic, 2011; Kisler et al., 2017a). Vascular dysregulation precedes many other deficits
that present in the pre-clinical phase of AD, suggesting it may have a role in the earliest
aspects of the disease, or may even be a driving factor (Iturria-Medina et al., 2016). The
buffer of “watering the entire garden” does exist, and could therefore allow the brain to
function normally for extended periods of time during the pre-symptomatic phase of the
disease, but the effect of altered functional hyperaemia over time, and the exhaustion of
any compensatory mechanisms, could have serious consequences for neuronal health and
cognitive function. Work from Kisler et al. (2017b) utilising a phosphorescent probe that
decays at rate proportional to the oxygen partial pressure, showed that perturbations in
the functional hyperaemia response may contribute to the presence of hypoxic pockets
in the parenchyma, particularly at 200µm below the surface, where the energy source is
primarily the capillary bed. Hypoxic conditions have been shown to facilitate the formation
of plaques and tangles in AD and so could be a key player in the disease process (Fang
et al., 2010; Sun et al., 2006).
This finding, coupled with the knowledge that early vascular changes may be a driver of
the disease pathogenesis, make investigating functional hyperaemia in young mice, as in
this chapter, an important avenue of research.
The functional hyperaemia response has previously been shown to be defective in mouse
models of AD, particularly as a result of Aβ deposition (van Veluw et al., 2019; Niwa
et al., 2000; Iadecola et al., 1999; Zhang et al., 1997), however if NVC deficits could drive
the onset of the disease, then it is also important to study NVC in the absence of Aβ, as in
in this study. ApoE4 has previously been linked to decreases in NVC in an acute surgical
preparation (Koizumi et al., 2018). These changes were observed in the endothelium-
dependent component of the vascular response and were ameliorated upon superfusion of
a ROS scavenger.
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In this chapter I studied the NVC response more closely, in a chronic, awake preparation,
to better understand the effect of ApoE4. To do so I investigated how individual neurons
and blood vessels responded to sensory stimulation in APOE4 animals, and in addition,
how any alterations were reflected in the net responses across the region.
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4.2 Aims
In order to fully understand how neurovascular coupling mechanisms are affected by
ApoE4, it is imperative to study both neuronal and vascular properties. The work in
this chapter aimed to investigated these properties at a micro- and macroscopic level in
order to address several key questions:
1. Does neuronal activity, in response to visual stimulation, differ in young
APOE4 mice, compared to young APOE3 mice?
In order to assess the adequacy of the energy supply, it is also important to examine energy
demand. APOE4 mice have previously been found to exhibit a hyperexcitable phenotype,
thought to be as a result of the susceptibility of inhibitory GABA neurons to damage by
ApoE4 fragments, however this was primarily found in aged mice (14- 20 months old)
(Nuriel et al., 2017; Najm et al., 2019). Hyperactivity has also been demonstrated in hu-
man carriers, with default mode network hyperactivity observed in young healthy adults,
as well as in AD patients (Najm et al., 2019; Filippini et al., 2009). Conversely, ApoE4
plays a role in synaptic failure, resulting in decreased spine density and reduced neurite
outgrowth, compared to APOE3 carriers. These effects are thought to occur from a young
age in APOE4-TR mice (Rodriguez et al., 2013; Dumanis et al., 2009), although not all
studies were carried out in the cortex. Work from Bell et al. (2012) showed that neur-
onal responses to stimulation were reduced in ApoE4 mice. It was therefore possible that
there would be a reduction in neuronal activity in the mice in this study, however limited
evidence from previous work suggested that neural activity in APOE4 mice of this age
would be similar to APOE3 responses (Koizumi et al., 2018). Nevertheless, characterising
the neuronal response to visual stimulation allowed me to estimate energy demand, as
well as study individual neuronal properties. To fulfil this aim, 3-4 month old APOE-TR
mice with GCaMP6f in excitatory neurons, were imaged during visual stimulation using
two-photon microscopy. Individual neuronal responses were recorded and the magnitude
of response, the response frequency and cell characteristics were determined.
2. How do blood vessels respond to the neuronal demand?
In order to determine how much blood was delivered to the activated region, stimulus
evoked blood vessel diameter changes, alongside red blood cell velocity changes, were
measured across the vascular tree. Debate exists over the role of capillaries in the func-
tional hyperaemia response with some arguing that they have a more passive role in NVC
(Hill et al., 2015), whilst others suggest that they are critical players in this response
(Hall et al., 2014) and may be the site of pathological changes in AD. Evidence from Bell
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et al. (2012) points to pericytes present on capillaries as a possible site of dysfunction in
APOE4-TR mice. In measuring these vascular parameters across the entire tree, it allowed
for the evaluation of the role of capillaries in the NVC response in these mice, as well as
determining if there were any vascular compartments particularly susceptible to ApoE4
mediated dysfunction. By comparing the neuronal energy demand with the blood supply,
an estimation of energy balance in APOE4 mice, compared with APOE3 mice, could be
elucidated.
3. Are there any perturbations to net haemodynamic properties in APOE4
mice? Net responses are invaluable for determining if any detected disruptions to indi-
vidual vascular dynamics, have an impact on the global response. Haemoglobin spectro-
scopy offers the further advantage of showing the oxygenation state of the haemoglobin in
the blood. During neuronal activation, the total haemoglobin (HbT) increases as the blood
flow to the area increases. Along with this influx of fresh blood, is an influx of oxygen-
ated haemoglobin (HbO) as deoxygenated haemoglobin (HbD) is washed away. An initial
increase in HbD is sometimes observed in response to stimulation, as the Hb becomes
deoxygenated before the influx of HbO arrives. As with the individual vessel responses,
the magnitude of the vascular response should increase or decrease in concert with the
neuronal demand, as has previously been demonstrated (Shabir et al., 2020). Stimulus
triggered responses across the entire V1 area were recorded to asses the impact of any
observed vascular and neuronal effects, on the overall regional activity.
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4.3 Methods
4.3.1 In vivo data collection
Animals aged 3-4 months old were surgically prepared with a chronic cranial window
as previously described (see section 2.2). The number of animals per experiment varied
(see Appendix A for details) but were balanced according to APOE genotype and sex.
A mixture of APOE-TR/DsRed and APOE-TR/Thy1GCaMP6f animals were used for
all experiments recording from the vasculature, and APOE/Thy1GCaMP6f animals only
were used for neuronal recordings. Recordings from each animal were made across 1-3
imaging sessions, with each session not exceeding four hours in duration, as per home
office requirements.
Prior to two-photon experiments, mice were injected intravenously or subcutaneously with
a fluorescent dye (FITC-dextran or Texas Red Dextran), allowing for the visualisation of
the vascular lumen. Neuronal and vascular recordings were made in the same imaging
sessions but haemoglobin spectroscopy/LDF measurements were taken on separate days
to minimise interference from the fluorescent dye. Mice underwent the visual stimulation
paradigm as previously described (see section 2.4.1), in brief, mice were head-fixed atop a
running cylinder and visual stimuli consisting of drifting grating patterns were presented
for 5 seconds with an interstimulus interval of 20 seconds. Mice were presented with 20
trials on average.
4.3.2 In vivo data analysis
Data processing
All data was extracted by the methods previously outlined in chapter 2 (see section 2.4.2),
resulting in a continuous vessel diameter, red blood cell velocity, neuronal fluorescence
or net haemodynamic trace. These traces were subsequently cut into visual stimulation
trials to allow for the averaging across stimuli. Vascular responses were normalised to
the four seconds prior to visual stimulation and multiplied by 100 to reflect percentage
change. Neuronal trials were normalised in the same way (but without the conversion
to a percentage change) to give a ∆F/F signal. Trials were classified according to the
locomotion that occurred before and/or during the visual stimulation. Trials with no
locomotion events in the two seconds preceding the visual stimulation or during the visual
stimulation period were grouped together as “no locomotion trials” to undergo further
analysis. A pre-stimulus period of two seconds was selected to allow for a return to baseline
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following a locomotion epoch, before the presentation of a stimulus. All locomotion events
that were less that one third of a second in length and were more than one second apart
from adjacent epochs, were not counted as “true” locomotion, to allow for small jitters of
the wheel.
As capillary measurements of diameter and RBCV were particularly susceptible to motion
artefacts, large fluctuations were removed resulting in gaps in data as previously described.
Trials missing more than 10% of the data during the stimulation period were excluded (see
figure 4.1A) and those that remained were interpolated to fill in the missing values using
a moving mean average (figure 4.1B). Traces were also smoothed using a loess smoothing
method (smoothing range: 1-5% span of the total number of data points, depending on
which best represented the shape of the data, (figure 4.1C)). Interpolated data was only
used to determine area under curve (AUC) values, for all other analyses, either raw or
smoothed traces were used.
Figure 4.1: Line scan processing during visual stimulation A) An example trace with >10%
of data missing during stimulation period (grey rectangle) that was excluded from further analysis.
B) An example trace with missing values (black) that were interpolated using a moving mean
average (pink). C) An example of a raw trace (black) and the same trace smoothed using a loess
smoothing method (pink).
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Response Size to visual stimulation
As outlined in the main methods section 2.4.2, in neuronal recordings, a region of interest
(ROI) was placed over each individual cell. Trials were averaged across neuronal ROIs
to give an average trace per ROI, which were subsequently averaged per animal. The
AUC was measured per ROI and averaged per animal. All trials per vessel were averaged
together to provide an average vessel trace. This was plotted and the AUC for each vessel
was determined.
Average cell traces, and individual vessel trials, were then classified as responsive or non-
responsive using custom written scripts in MATLAB. Traces were classified as responsive
if the maximum peak (averaged over 0.5s around the true maximum peak to prevent
single noise spikes resulting in a trace being incorrectly defined as responsive) of the trace
during the visual stimulation period exceeded a predefined threshold. Thresholds of twice
the standard deviation of the baseline period were applied to neuronal, pial diameter and
capillary diameter traces and one times the standard deviation of the baseline period was
applied to RBCV traces. Threshold values were decided for each data type based on the
value that gave the most accurate results for a subset of each data type.
In neuronal data, AUC measurements were obtained from responsive cell traces that were
subsequently averaged per animal. A response frequency was determined by calculating
the percentage of responsive cells per animal.
All responsive trials per vessel were averaged to give an overall responsive trace per
vessel. AUC measurements were made for each responsive trace. A response frequency
was determined by calculating the percentage of responsive trials per vessel and grouping
together vessels from animals of the same genotype.
Net haemodynamic traces were averaged per animal as the same region was meas-
ured across on each imaging session. AUC values were obtained from each average trace
per animal.
In order to quantify how much vascular response there was per “unit” neuronal activity,
a neurovascular coupling index (NVCi) was calculated, where vascular responses were
normalised to neuronal responses. This was done in two different ways. First, the average
neuronal AUC of responsive cells during visual stimulation was determined per animal,
and subsequently divided into the average AUC of each vessel average from that animal.
As the purpose was to glean how the energy balance differed across animals, only the
AUC of responsive ROIs was used as this best reflects energy demand, and the AUC of
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the vessel average across all trials (i.e. not just responsive trials) was used, as this is
what best reflects energy delivery. Although this method is attractive as it allows for the
vascular responses in each animal to be normalised to its own average neuronal response,
it does mean vascular data from animals lacking GCaMP6f in their neurons (as is much
of the data in this chapter) cannot be taken into account with this measure. In order to
overcome this, a second NVCi method was utilised, where an average neuronal AUC per
genotype was determined and all vessel AUCs in this genotype group were normalised to
this value.
Neuronal characteristics
Neurons were classified as “on” , “off” , “both” or “neither” depending on whether they had
a maximum peak two standard deviations above the baseline period during the stimulation
(on), in the two seconds following the end of the visual stimulation (off), during both the
stimulation and post-stimulation period (both) or not at all during either of these time
periods (neither). In addition, the number of peaks above the specified threshold in the
∆F/F trace during visual stimulation were detected and converted to peaks per minute.
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4.4 Results
4.4.1 Effect of APOE4 on neuronal responses to visual stimulation
In order to assess neuronal activity in the visual cortex of APOE4 mice compared to
APOE3 mice, the magnitude of response sizes (i.e. the area under the curve of ∆F/F
traces during the stimulus period) were compared. The magnitude of ∆F/F signals are
tightly coupled with the number of spiking events (Akerboom et al., 2012), and so is an
appropriate measure of neuronal activity and therefore energy demand.
Initially, all cells were analysed to compare response magnitudes between genotypes.
APOE4 mice exhibited an increased response size during visual stimulation (figures 4.2A,
B). Response frequency was then determined to establish whether or not one genotype
was more likely to respond to visual stimulation than the other, however there was no
observed effect of genotype (figure 4.2C). In order to better assess energy demand during
the visual stimulation, responsive cells were analysed separately. In terms of energy
use, this is likely to be a more accurate representation, as non-responsive cells will not
require the oxygen and glucose delivered in the blood, but they will reduce the average
∆F/F signal. The magnitude of evoked responses of responsive cells only revealed the
same results, APOE4 mice had a larger response size than APOE3 mice (figures 4.2D, E)
reflecting an increase in stimulus triggered neuronal activity.
Rather than averaging across animals, I then used an alternative analysis, a linear mixed
model, which analyses all data from individual cells while accounting for variance within
animals. This yielded similar results as the animal average, with APOE4 cells showing
larger response sizes to visual stimulation (p =0.0386 (all cells), p = 0.042 (responsive
cells only)).
To further probe for any differences in neuronal behaviour, I calculated the frequency
of calcium transients during the stimulation period. An example of detected peaks can
be seen in figure 4.2H. No difference in the number of transients per minute was found
between genotypes (figure 4.2I), suggesting that it is only the magnitude of events that
differs between the genotypes, driving the increased ∆F/F response observed. Although
it is important to note that spikes occurring in quick succession (i.e. a spike train) will
appear as only one peak in the trace, the magnitude of which will reflect the amount of
spiking in this train. Therefore, in this case, it was the number of spikes in a burst of
action potentials that was changing, not the frequency of the bursts themselves.
The classification of cells based on their response to visual stimulation has previously
been used to probe for disruptions in visually evoked responses (van Veluw et al., 2019).
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Neurons that responded exclusively to the visual stimulation were termed “on” cells
(figure 4.2F, top panel). As well as this type of cell, there were others that responded
exclusively to the offset of the visual stimulation, a previously established phenomenon
(Liang et al., 2008; Jin et al., 2008). These cells were were termed “off” cells ( figure 4.2F,
second panel). Cells that exhibited both behaviours were termed “both” and those that
did not exhibit any activity in response to visual stimulation were called “neither” (
figure 4.2F, bottom two panels). “Neither” cells made up the majority of cells, and
of those that responded, “on” cells were the most abundant. There was no observed
difference in the distribution of cell types between genotypes (figure 4.2G). In addition all
data was averaged per cell, rather than across animals and the same results were found
across all parameters (see B.2).
Results appear to point towards a hyperactive phenotype of visually evoked re-
sponses in the visual cortex of APOE4 mice but also suggests that, in these same mice,
there is an absence of a disruption to the overall network activity and that the cell
firing patterns remain intact. In the context of energy demand, these data imply that
APOE4 mice might have an increased demand for energy during visual stimulation.
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Figure 4.2: Neuronal Responses to visual stimulation A. Average ∆F/F traces of all cells
averaged per animal in responsive to visual stimulation. B. AUC measurements for animal averages
shown in A. C. Response frequency of cells per animal for APOE3 and APOE4 animals. D.
Average ∆F/F trace of all responsive cells averaged per animal, in APOE3 and APOE4 mice
during visual stimulation. E. Area under curve measurements for the responsive cells averaged
per animal in D. F. Example ∆F/F traces for each cell type “On, Off, Both and Neither”. G.
The distribution of cell types outlined in F in APOE3 and APOE4 animals. H. Example ∆F/F
trace during visual stimulation. Purple circles show peaks detected during stimulation and above
threshold (dashed grey line). I. PPM values for all responsive APOE3 and APOE4 cells averaged
per animal. Grey rectangles represent the onset and offset of visual stimulation. Individual points
represent individual animal averages and error bars represent SEM. For detailed statistical outputs
see table A.9
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4.4.2 Vascular responses to visual stimulation
In order to assess if this increase in neuronal activity was being met with an increased
blood supply in APOE4 mice, vascular responses to the same visual stimulation were de-
termined.
The diameters of large pial blood vessels and small parenchymal capillary blood vessels,
as well as capillary RBC velocity, were recorded over the course of the stimuli. A robust
increase in diameter and RBC velocity was observed upon presentation of a visual stim-
ulation (see figure 4.3). Increases in pial diameter and capillary RBCV in response to
visual stimulation, were found to occur more frequently in APOE3 mice than in APOE4
mice (see figure 4.4A, G). The response frequency of stimulus evoked capillary diameter
increases did not differ between genotypes (figure 4.4D).
As trials with significant amounts of locomotion were excluded from this analysis, some
vessels had only very few contributing trials, meaning only very high or low response fre-
quencies were possible. To examine the effect this might have on the results, the number
of contributing trials per vessel was plotted against the response frequency ( figures 4.4B,
E, H). Indeed it can be seen that a large number of the extreme response frequencies (i.e.
0% and 100% response frequencies) were as a result of vessels with low numbers of trials.
A cut off of a minimum of 10 trials was applied to eliminate this confound. This resulted
in pial vessel diameter changes that were no longer significantly less responsive in APOE4
mice when compared to APOE3 mice, although they did trend towards significance (fig-
ure 4.4C, p = 0.0824). However, both capillary diameter increases (figure 4.4F) and RBC
velocity increases (figure 4.4I) in response to stimulation, occurred more frequently in
APOE3 mice when this threshold was applied. This presents a picture of vascular un-
reliability in the visual cortex of young APOE4 animals despite their elevated neuronal
responses.
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Figure 4.3: Vascular responses to visual stimulation Left panel: Example pial arteriole before
and during stimulation. Red dashed lines show the outline of the vessel before stimulation. Right
Panel: Example RBCV linescan showing the dark shadows cast by RBCs before and during visual
stimulation. Flatter stripes represent cells that are travelling faster. Capillary diameter increases
are generally small and difficult to see by eye, therefore an example is not shown.
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Figure 4.4: Vascular response frequency to visual stimulation A. Response frequency per
vessel in pial arterioles. B. Response frequency plotted against the number of contributing trials
per vessel in pial arterioles. C. Response frequency per vessel in pial arterioles with more than 10
contributing trials. D. Response frequency per vessel in capillaries. E. Response frequency plotted
against the number of contributing trials per vessel in capillaries. F. Response frequency per vessel
in capillaries with more than 10 contributing trials. G. Capillary RBCV response frequency per
vessel. H. Capillary RBCV response frequency plotted against the number of contributing trials
per vessel. I. Capillary RBCV response frequency per vessel in capillaries with more than 10
contributing trials. Grey line in B, E and H represents the 10 trial minimum threshold applied.
Individual points represent vessels. Error bars represent SEM. For detailed statistical outputs and
n numbers see table A.10
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To continue the investigation into the ability of the vasculature to meet neuronal demands
and following the finding that APOE4 animals have a less reliable energy supply, the size
of the stimulus evoked vascular responses were studied. As mentioned, under physiological
conditions, it would be expected that the vascular increases would be amplified to match
the hyperexcitable neuronal responses. When looking at overall vessel averages, there was
no significant difference between genotypes in the response magnitude of pial or capillary
diameter changes, or in capillary RBC velocity changes (see figures 4.5A, B, E, F, I, J).
As with the neuronal data, a more complex analysis was applied, a linear mixed model
that accounted for the variability within each vessel. This analysis again showed that
there was no effect of genotype on the magnitude of responses across all three measures
(AUC: pia p = 0.7059, capillary diameter p = 0.254, capillary RBC velocity p = 0.263).
Next, responsive trials only were averaged to give average vessel traces, the magnitude
of which were then measured. As before, there was no effect of genotype on response
size in any of the groups (figures 4.5, C, D, G, H, K, L), a finding that was confirmed
with a linear mixed model (AUC: pia p = 0.486, capillary diameter p = 0.7546 , capillary
RBC velocity p = 0.9604). This failure of the blood vessels to dilate further to match
the elevated levels of neuronal activity, coupled with the reduction in the reliability of
responses, points towards a vascular insufficiency in APOE4 mice.
Vascular responses to visual stimulation A. Average stimulus induced diameter
changes in pial arterioles, averaged per vessel. B. AUC measurements for the diameter
changes shown in A. C. Average stimulus induced diameter changes in pial arterioles,
responsive trials only averaged per vessel. D. AUC measurements for the diameter changes
shown in C. E.Average stimulus induced diameter changes in capillaries, averaged per
vessel. F. AUC measurements for the diameter changes shown in E. G. Average stimulus
induced diameter changes in capillaries, responsive trials only averaged per vessel. H.
AUC measurements for the diameter changes shown in G. I. Average stimulus induced
velocity changes in capillaries, averaged per vessel. J. AUC measurements for the velocity
changes shown in I. K. Average stimulus induced RBCV changes in capillaries, responsive
trials only averaged per vessel. L. AUC measurements for the velocity changes shown in
K. Grey rectangles represent the onset and offset of visual stimulation. Individual points
represent individual vessels and error bars represent SEM. For detailed statistical outputs
and n numbers see table: A.11
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Figure 4.5: Vascular responses to visual stimulation Figure legend on previous page.
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To quantify the amount of vascular response per “unit” neuronal activity, a neurovascular
coupling index (NVCi) was created for each data set, where vascular responses were
normalised to neuronal responses both within animals and across all vessels (see section
4.3.2)). A higher NVCi reflects a greater supply of blood (i.e. energy) in response
to neuronal activity (i.e. demand). Pial vessels showed decreased NVC indices in
APOE4 animals (figure 4.6A, B) and capillary RBC velocity NVC indices followed
the same pattern, being lower in APOE4 animals (p = 0.055 (animal average), p =
0.054 (vessel average) (figure 4.6E, F). As the NVC indices for capillary diameters
were not different between genotypes (figure 4.6C, D), it suggests that the RBC velocity
differences were driven by upstream changes in flow, not downstream changes in resistance.
On the whole, vascular data suggests that the capillaries and possibly pial vessels
are less likely to increase their diameters in response to neuronal activation in APOE4
mice. NVCi measurements imply that imbalances between the neuronal and vascular
responses occur primarily at the pia, presumably as a result of the lower summed activity
from the unreliable capillary bed. These pial effects may then drive the deficits observed
in the RBC velocity increases. It is clear that there is a mild vascular deficit present in
these young APOE4 animals, where there is a failure to meet increased neuronal activity
with a corresponding increase in blood supply.
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Figure 4.6: Neurovascular coupling indices A. Pial NVCi calculated using neuronal averages
per animal. B. Pial NVCi calculated using neuronal averages per genotype. C. Capillary NVCi
calculated using neuronal averages per animal. D. Capillary NVCi calculated using neuronal
averages per genotype. E. Capillary RBCV NVCi calculated using neuronal averages per animal.
F. Capillary RBCV NVCi calculated using neuronal averages per genotype. Individual points
represent vessels. Error bars represent SEM. For detailed statistical outputs see table A.12.
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4.4.3 Net responses to visual stimulation
Finally, subtle changes in the neurovascular coupling mechanisms at an individual
neuronal and vascular level may or may not produce significant changes in regional
measures of blood flow and haemodynamic responses. In order to investigate this, the
Oxy-CBF probe utilised LDF and Hb spectroscopy, allowing for global responses from
across the visual cortex to be determined. Example profiles of representative HbT, HbD,
HbO and SO2 responses to visual stimulation, as measured by Hb spectroscopy, are seen
in figure 4.7A. The stimulus evoked increase in CBF (flux) as measured by LDF can
be seen in figure 4.7B, and the CMRO2, calculated from these parameters, can been
seen in figure 4.7C. Increases in CMRO2 are thought to be indicative of net increases
in neuronal activity. When comparing all of these parameters, the response magnitude
was not significantly different between genotypes. Nevertheless the direction of the
differences in these net measures was generally in the direction that would be predicted
by the measurements obtained from single cells and vessels. The traces show a slight,
non-significant decrease in the APOE4 response to stimulation in HbT, HbO and SO2
measurements (figures 4.7E, F, H), it seems that the subtle changes in the vasculature
observed in two-photon experiments may have an impact on the macroscopic responses,
although large variations in the data make this impossible to irrefutably conclude. Of
particular interest is the apparent reduction in blood SO2 in APOE4 mice, when compared
with APOE3 mice. This may reflect a higher extraction of O2 from the vessels in APOE4
mice, as a result of the increased neuronal activity, presumably resulting in larger energy
demands in the tissue, coupled with the less reliable blood supply. In line with this, the
HbO maximum appears to be somewhat lower in APOE4 mice, possibly reflecting the
same scheme whereby more oxygen is being extracted from the blood in these animals.
The small reduction in HbT magnitude, thought to be indicative of total blood volume,
fits with the information gleaned from the previous chapter and this one, reduced vascular
density coupled with an unreliable blood supply would lead to a reduction in the blood
volume delivered. Surprising are the results for flux and CMRO2 (figures 4.7D, I). An
increase in neuronal demand would be expected to lead to an increase in CMRO2, however
it is possible that the large numbers of non-responsive neurons (>60% of all cells, figure
4.2F, G) meant that the CMRO2 measurement cannot detect the increase in activity of
the responsive “on” cells. In addition, as CMRO2 combines the error from HbT, HbD
and CBF measurements, it is often noisy. Finally, another unexpected outcome was the
striking similarity of the CBF response in both genotypes (figure 4.7D). Individual capil-
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lary measurements indicated that there might be a reduction in the response frequency
of RBC velocity in APOE4 animals, that is not reflected in these net measurements. One
speculation might be that the reduction in CBF as a result of the reduced responsiveness
of the vessels is subtle and therefore cannot be detected within the error of these data.
Net haemodynamic responses to visual stimulation Figure on following page.
A. Example haemodynamic parameters SO2 (Oxygen Saturation), HbO (Oxygenated
Haemoglobin), HbD (Deoxygenated haemoglobin), HbT (Total haemoglobin), B. Blood
flow (Flux) and C. CMRO2 responses to visual stimulation. D. Left panel: Average
stimulus evoked changes in flux in APOE3 and APOE4 mice. Right panel: AUC meas-
urements for flux changes represented in the left panel. E. Left panel: Average stimulus
evoked changes in HbT in APOE3 and APOE4 mice. Right panel: AUC measurements
for HbT changes represented in in the left panel. F. Left panel: Average stimulus evoked
changes in HbO in APOE3 and APOE4 mice. Right panel: AUC measurements for HbO
changes represented in the left panel. G. Left panel: Average stimulus evoked changes in
HbD in APOE3 and APOE4 mice. Right panel: AUC measurements for HbD changes
represented in the left panel. H. Left panel: Average stimulus evoked changes in SO2 in
APOE3 and APOE4 mice. Right panel: AUC measurements for SO2 changes represented
in the left panel. I. Left panel: Average stimulus evoked changes in CMRO2 in APOE3
and APOE4 mice. Right panel: AUC measurements for CMRO2 changes represented
in the left panel. Grey rectangles represent the onset and offset of visual stimulation.
Individual points represent individual animals and error bars represent SEM. For detailed
statistical outputs see table A.13.
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Figure 4.7: Net haemodynamic responses to visual stimulation. Figure legend on previous
page.
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4.4.4 The Effect of Sex and ApoE on Response Size and Frequency
As in chapter 3, the effect of sex on the NVC response was examined. AUC measurements
for all vessels/cells were split by sex and APOE genotype to determine if there was any
effect of sex or an interaction between sex and genotype. For pial and neuronal AUC
measurements, there was no effect of sex (figure 4.8A, G). However for capillary diameter
changes there was an observed interaction between sex and genotype (figure 4.8C), as
well as an effect of sex on RBC velocity measurements (figure 4.8E). Males had smaller
capillary responses in APOE4 mice, although it must be noted that a small number of
extreme outliers do exist in the data.
Response frequency was also used to test for any effects of sex on the reliability of
responses to stimulation. In pia and RBC velocity measurements, no effect was ob-
served (figure 4.8B, F), however in the capillary diameter measurements, sex had a
significant effect with females tending to respond more frequently than males (figure
4.8D). Similarly in the neuronal data, APOE4 females had neurons that fired more
frequently than APOE3 females (figure 4.8H). Overall there appeared to be a mild
effect of sex on some of these measures, however some of these effects were influenced
by outliers. In addition the effects were not consistent or robust across all parameters.
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Figure 4.8: The effect of sex on response size and frequency A. Responsive pial vessel
AUC, split by sex for APOE3 and APOE4 mice. B. Pial response rate, split by sex for APOE3
and APOE4 mice. C. Responsive capillary AUC, split by sex for APOE3 and APOE4 mice. D.
Capillary response rate, split by sex for APOE3 and APOE4 mice. E. Responsive RBCV AUC,
split by sex for APOE3 and APOE4 mice. F. Capillary RBCV response rate, split by sex for
APOE3 and APOE4 mice. G. Responsive cells AUC, split by sex for APOE3 and APOE4 mice.
H. Cell response rate, split by sex for APOE3 and APOE4 mice. Individual points represent vessel
averages and violin plots show data across all cells. For detailed statistical outputs see table A.14.
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4.5 Discussion
In this chapter, two-photon imaging, Hb spectroscopy and laser Doppler flowmetry were
used to probe how the properties of individual elements of the neurovascular coupling
response varied with APOE genotype and what effect this had on overall net activity.
4.5.1 Results Summary and Interpretation
Increased neuronal activity during visual stimulation in APOE4 mice
In APOE4 mice, neuronal responses to visual stimulation were increased. This finding
is consistent with previous reports of hyperexcitability in APOE4 carriers as a result
of the increased susceptibility of GABAergic inhibitory neurons to damage from neuronal
ApoE4 fragments (Brecht et al., 2004; Li et al., 2009; Knoferle et al., 2014) and subsequent
disinhibition of excitatory neurons. It was unclear whether or not we would observe this
phenotype in such young animals as previous reports from APOE-TR mice suggested
that neuronal responses should be intact or diminished at this age (Koizumi et al., 2018;
Bell et al., 2012). In one such report, the investigators used a voltage-sensitive dye to
measure voltage changes in 4 months old animals in response to a hindlimb stimulus and
observed reduced activity in APOE4 mice (Bell et al., 2012). The animals used in this
particular study were generated in house in the same way animals used in this thesis
were generated and on the same background strain (Sullivan et al., 1997; Knouff et al.,
1999), however one cannot rule this out as a source of variability. Another study using
the same mouse model determined that neuronal activity was unlikely to be altered as
Ca2+ increases in the neuron, as a result of NMDA application, were unaffected (Koizumi
et al., 2018), but as this method was carried out in isolated neurons it would not capture
the disinhibition that may be responsible for the hyperexcitability observed in this study.
From the data outlined, it was evident that it was the response size that was increased in
APOE4 animals (i.e. the amount of firing in a single burst), rather than the frequency of
peaks (each representing a burst of action potentials) or the distribution of cell response
types (i.e. On, Off, Both, Neither).
When comparing magnitudes of GCaMP fluorescence it is important to be mindful of a
number of factors. First is that the variation in the signal-to-noise ratio between animals
could result in a variation in ∆F/F signals. In this study, a background signal for each
cell was generated and subtracted as outlined in the main methods section (2.4.2), which
would diminish this variability and have the added benefit of removing any light artefacts
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arising from the visual stimulation. Another important consideration, is the supralinearity
of GCaMP (Akerboom et al., 2012). This means the values obtained when measuring the
magnitude of the ∆F/F signals are not entirely quantitative, so we can be confident that
there was more activity in APOE4 mice, just not precisely how much more.
With all of this in mind, we can conclude from the data presented in this chapter that
there was increased neuronal activity in APOE4 mice during visual stimulation. From
this we can speculate that APOE4 animals might have a greater demand for oxygen and
glucose during sensory stimulation, in which case, it would expected to see a corresponding
increase in the blood supply in APOE4 animals to meet this demand.
Reduced response frequency in APOE4 vasculature
Vascular data was then analysed to determine if the expected increase in vascular activity
to meet the neuronal demand, was present. Initially the response frequency was analysed
and a cut off of a minimum of 10 contributing trials per vessel was set. Without an
applied threshold of ten trials, the pial and RBCV responses occurred less frequently in
APOE4 mice, whereas the capillary diameter responses were not different between the
two genotypes. The application of the cut off, in order to abrogate the extreme influence
of vessels with a small number of trials, did alter the findings. After this application,
the pia was no longer significantly less responsive (although the data trended in this
direction), but the capillary diameters and RBCVs were. This reduction in response
frequency demonstrates a degree of vascular unreliability in APOE4 animals, particularly
when it comes to the capillary bed.
Failure of APOE4 mice to elevate vascular responses to match elevated neur-
onal activity
In conjunction with the disruption to response frequencies, further vascular insufficiency
in APOE4 mice was evident from the discovery that there was an inability of blood vessels
to increase their response size (i.e. the dilation or RBC velocity) to match the increased
neuronal activity. Vasodilations at the pia are as a result of propagated responses from
downstream vessels that are closer to neurons (Iadecola et al., 1997; Chen et al., 2014;
Longden et al., 2017; Rungta et al., 2018). Therefore, a plausible scheme is one whereby
there are less reliable responses in the capillary bed of APOE4 mice and these summate
upstream at the pia at an insufficient magnitude to match the increased neuronal response.
This was reflected in the reduced pial and capillary RBCV NVCi measurements in APOE4
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animals.
Net haemodynamic measurements show trends that reflect, in part, two-
photon observations
Net haemodynamic measurements offer a valuable insight into the overall, macroscopic
effects of the microscopic observations. As discussed, some results obtained from these
net readings were surprising, there was no observed increase in the magnitude of CBF
responses in APOE3 mice, nor was there an increase in the CMRO2 measurement in
APOE4 mice. Despite this, the net recordings have offered some insights into the NVC
process in APOE4 animals. In the absence of an increased blood supply in APOE4 an-
imals, the pattern towards slightly reduced HbO and SO2 levels during stimulation, could
reflect a greater oxygen extraction fraction (OEF) from the blood in an attempt to meet
the increased energy demands in the parenchyma. Perhaps this is a compensatory meas-
ure in these young animals that allows them to continue to function at a physiologically
“normal” level despite the increased neuronal activity and reduced vascular reactivity.
Alternatively, the possible reduction in HbO levels could purely reflect the trend towards
a reduced blood volume delivery during visual stimulation, probably as a result of both a
reduced vascular density and a less reliable NVC mechanism in APOE4 mice. What was
clearly not present, as with the two-photon experiments, was an increase in net responses
in APOE4 animals to match the increase in neuronal activity.
A different study in APOE4-TR mice reported a net decrease in CBF in response to a
sensory stimulation when compared to APOE3-TR or WT mice (Koizumi et al., 2018).
Some key experimental differences might explain why this result is inconsistent with our
measurements. Firstly, the use of anaesthesia in these experiments could account for
the differing results, as the increase in energy use by the tissue during activation com-
pared to during rest, is greater in anaesthetised animals than in awake animals (Shulman
et al., 1999). This is as a result of a lower resting energy use in anaesthetised animals
and would therefore result in a larger percentage increase from baseline in response to
stimulation. Conversely, another study has shown that haemodynamic responses can be
preserved whilst mice are under anaesthesia (Sharp et al., 2015). It is likely that these
effects vary with regime and whether APOE4 can modulate this in any way is unknown,
but it nevertheless an interesting experimental difference to consider. Another possible
explanation is that the experiments carried out by Koizumi et al. (2018) utilised an acute,
rather than a chronic preparation. It is now well documented that APOE4 carriers have
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an increased response to inflammatory stimuli due to mechanisms that involve enhanced
microglial activation (Safieh et al., 2019; Rodriguez et al., 2014) and increased levels of
pro-inflammatory cytokines (Fan et al., 2017; Ophir et al., 2005) and so a reasonably in-
vasive procedure, such as a craniotomy with dura removal, may have acute effects on the
NVC response in APOE4 mice as a result of increased inflammation, rather than as a
direct interaction between the vasculature and APOE4.
4.5.2 Overall discussion
The results presented in this chapter show APOE4 animals to have increased neuronal
activity coupled with subtle, yet robust vascular deficits. This could, over time lead to an
energy imbalance, where increased neuronal energy demands are not met with adequate
energy supply, although such a deficit is not yet present in the global measurements.
As both the pia and capillaries are affected, and as mentioned the pial dilations are
propagated from downstream vessels, perhaps the capillary bed is the initial site of
dysfunction. Certainly, the idea that capillary dysfunction may be an important driver in
the AD process is not a new one, with mathematical models suggesting that perturbations
in capillary blood flow in AD could be the first step in a series of deleterious events,
resulting in a degree of tissue hypoxia (Østergaard et al., 2013) and the aforementioned
work from Nortley et al. (2019) showing convincing evidence that Aβ interacts with
capillary pericytes, inducing constrictions as a result of reactive oxygen species production
(Nortley et al., 2019). Specifically with reference to ApoE, there is evidence pointing
towards capillary pericytes as key sites for ApoE4 meditated dysfunction. Studies
from the Zlokovic group have shown there to an upregulation of a pro-inflammatory
CypA-NF-κB-MMP9 mediated pathway in the pericytes and endothelial cells of APOE4
carriers (Bell et al., 2012; Halliday et al., 2016) that results in DNA damage in both
these cell types. Indeed a recent study from the same group showed that human ApoE4
carriers have markers of pericyte injury in the cerebrospinal fluid and that the severity of
this injury correlates with the cognitive trajectory of these patients, as well as with BBB
permeability (Montagne et al., 2020).
A very interesting research question is what role do endothelial cells play in this
dysfunction? The endothelial damage described by Bell et al. (2012) and Halliday
et al. (2016), compliments the findings from Koizumi et al. (2018) showing it was the
endothelium-dependent compartment of functional hyperaemia that was attenuated in
101
APOE4 animals. It would also be consistent with some of our findings in chapter 3 and
in this current chapter. Endothelial cells are essential for the propagation of vasodilatory
signals from downstream vessels to the pia (Chen et al., 2014; Longden et al., 2017) as
well as for the conductance of vasomotion via gap junctions. Damage to endothelial cells
could therefore result in dysfunctional signal conductance as well as aberrant endothelial
signalling to the vasculature, resulting in less reliable responses at the capillary bed that
are ineffectively propagated to the pia and therefore do not match the increased neuronal
demand. Not only this, but endothelial damage could also account for the reduced
vasomotion observed in APOE4 mice, if oscillations are not being effectively conducted
along the vasculature. Future work, studying the endothelium of APOE4 mice would
help to answer this question. Such experiments could include an investigation into the
conductance of the endothelium in APOE4-TR mice as well as the physical properties of
the cells such as the morphology or luminal coverage.
The work from Koizumi et al. (2018) pointed towards ROS as a potential reason for
the vascular dysfunction. Studies suggest that ROS and CypA exist in a cycle, at least
in VSMCs, where an increase in one, leads to an increase in the other (Satoh et al.,
2010), so it is plausible that this pro-inflammatory pathway in pericytes and endothelial
cells involving CypA, also involves ROS production. This could result in the damage
of key cells in the neurovascular unit, pericytes and endothelium, but also a reduction
of NO availability as it interacts with the ROS, superoxide, to produce peroxynitrite
(Garthwaite, 2018), itself a molecule that exerts vascular damage (Girouard et al., 2007).
ROS damage to VSMCs could also account for the reductions in vasomotion and the
reduced NVCi in pial vessels, so an interesting future experiment could involve co-staining
tissue for endothelial cells, pericytes or VSMCs with dihydroethidium to measure ROS
levels(Dikalov et al., 2007). This would show if there are high levels of ROS in a specific
cell type in APOE4 mice and so help to identify where the dysfunction is occurring
(Dikalov et al., 2007).
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4.5.3 Future work and limitations
In addition to the future work already mentioned throughout this chapter, an experi-
ment to determine if the vasomotor apparatus is functionally intact, such as a hyper-
capnia challenge, would be suitable. It would test the ability of the vasculature to dilate,
without modulating neuronal input (Jones et al., 2005) and would also not depend on the
propagation of dilations, a process that could be defective if endothelial damage has taken
place (Chen et al., 2014; Longden et al., 2017). This experiment would also shed light
on whether or not APOE4 vessels posses the ability to dilate any further or if they are
maximally dilated during the functional hyperaemia response.
4.5.4 Conclusion
In summary, the work in this chapter shows increased neuronal activity and mild vascular
dysfunction in APOE4 mice. Over time this could produce a mismatch in energy sup-
ply and demand. Although the underlying mechanisms in these experiments are unclear,
evidence from previous studies point towards endothelial and pericyte dysfunction as pos-
sible candidates. Over time this energy imbalance could worsen and eventually result in a
chronic hypoxia in the brain, which could facilitate the formation of the hallmark patholo-
gic features of AD, Aβ deposition and the hyperphosphorylation of tau (Fang et al., 2010;
Sun et al., 2006).
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Chapter 5
Effect of ApoE4 and Age on
Neurovascular Properties
5.1 Introduction
The previous work in this study has provided an in depth look into the neurovascular
coupling properties in young APOE4 and APOE3 mice. As previously mentioned, this
young time point is important as it shows the early effects of ApoE4, before cognitive
decline and AD would develop in humans. In addition to this age, two additional time
points were studied, to determine how the effects found in young animals might evolve
across a section of the lifespan.
5.1.1 Ageing and the neurovasculature
Age remains the single greatest risk factor for developing AD, and with APOE4 being the
greatest genetic risk factor for going on to develop AD (Corder et al., 1993), the interaction
and interplay between the two is of great interest. Ageing exerts a multitude of deleterious
effects on the neurovasculature (for full reviews see: Iadecola et al. (2009); Brown and
Thore (2011); Farkas and Luiten (2001)), including a thickening of the basement membrane
that correlates with atherosclerosis (Farkas et al., 2006; Farkas and Luiten, 2001), capillary
loss (Bell and Ball, 1981; Farkas and Luiten, 2001), pericyte degeneration (Iadecola et al.,
2009), reduced CBF (Kalaria, 2009) and attenuated blood flow increases in response to
sensory stimulation as a result of ROS produced from NADPH oxidase (Park et al., 2007).
These deficits could result in an inadequate energy supply to active neurons which can have
serious implications for neuronal health and cognitive function. Conversely, at least one
study has found the NVC response to be preserved in animals>19 months old (unpublished
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data - personal communication with Dr Kira Shaw).
5.1.2 ApoE and age
Consistent patterns of age dependent cognitive decline have been observed in APOE4
carriers compared to APOE3 carriers (Davies et al., 2014; Caselli et al., 2009), alongside
various structural and functional age dependent effects such as a decline in functional
connectivity and CBF in APOE4 carriers compared to WT controls (Zerbi et al., 2014)
and increased seizure activity in APOE-TR mice (Hunter et al., 2012). Although very
few longitudinal studies have been carried out investigating the effect of ApoE4 and age
on the neurovasculature, existing evidence suggests that age exacerbates multiple deficits
that exist in APOE4 mice. One such study is from Bell et al. (2012), where it was found
that pericyte coverage of the microvasculature, as well as microvascular length decreased,
and blood brain barrier permeability increased, in an age dependent manner from 2 weeks
to 12 months in APOE4 mice.
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5.2 Aims
This chapter aimed to fill in some of the existing knowledge gaps on the age dependent
effects of ApoE4 on neurovascular function. Animals were studied longitudinally at 3-4
months of age (young time point) and at 6-7 months (middle age point). In addition,
a separate small cohort of mice aged 12-13 months (old age point) were also tested.
According to the Jackson laboratory, mice at 1 year of age better represent the middle
aged human, rather than an elderly adult (Hagan, 2017). Therefore to gain further
information on the effect of ApoE4 in later life, an additional time point could be
considered e.g. 18- 24 months, however time constraints in this project meant that 12-13
month old mice were the oldest cohort that were tested. Despite this, the 6-7 month old
range was still referred to as the “middle” age point in this chapter, as it was the middle
relative to the other age points.
This chapter aimed to elucidate the neurovascular impact of age in
APOE4 compared to APOE3 animals. Specifically to determine:
1. Are neurovascular resting state parameters altered in middle aged
and old mice? Some deficits were observed in the baseline parameters in young
animals and so investigating these properties across a section of the lifespan will help to
determine if they are phenomena that exist only at young age or alternatively, if they
continue to present with, or are modulated by age. The resting state parameters are
of interest as they shed light on the baseline neurovascular conditions upon which the
neurovascular coupling response is elicited. In addition to this, I also wished to determine:
2. Are neurovascular coupling responses to visual stimulation altered in
middle aged and old mice? It has been reported that age alone can result in smaller
NVC responses to sensory stimulation (Park et al., 2007) and so, in combination with
ApoE4, attenuated responses to a sensory stimulation might be expected in older animals.
3. Do APOE4 mice exhibit any cognitive deficits at these age points?
Conducting some behavioural assays at each time point provides valuable information on




As described in the main methods section, animals had a cranial window implanted at
∼8 weeks of age and were imaged between 3-4 months of age as described in the two
previous experimental chapters. The majority of these mice were then aged to 6-7 months
and imaged again, according to the same experimental paradigms. A separate cohort of
mice were surgically prepared at ∼ 11 months of age, and imaged at 12-13 months of age.
Unfortunately it was impractical to track the same animals from young to old due to the
decreasing viability of the cranial window, and so separate cohorts were necessary.
5.3.2 Data Collection
All data collection was carried out in the same manner as described in the main methods
section and in the methods outlined in chapters 3 and 4.
5.3.3 Data Analysis
All data was analysed in the same way as described in the main methods section and in
chapters 3 and 4. All “young” data presented in this chapter is the same as that shown
in chapters 3 and 4.
5.3.4 Statistical analysis
Statistical analysis was carried out in SPSS. To determine the effect of age on each para-
meter, two-way ANOVAs were carried out. As primarily vessels or neurons were used
as subjects and crucially, old animals were a separate cohort, independent sample AN-
OVAs were carried out, rather than repeated measures. All error bars represent SEM and
detailed statistical outputs, as well as sample sizes can be found in Appendix A .
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5.4 Results
5.4.1 Effect of ApoE4 and Age on short term and spatial memory
Three behavioural assays were carried out to determine if the age points selected in this
study were accompanied with cognitive changes. A novel object recognition task was
performed to test short term memory (Clark et al., 2000) and a discrimination ratio was
calculated to quantify the amount of time spent with the novel object, compared to the
familiar object (figure 5.1A). There was no effect of age or genotype, nor was there an
interaction between age and genotype. Similarly, a spatial object recognition task was
carried out to assess hippocampal-dependent spatial memory (Dix and Aggleton, 1999).
There was no observed effect of age or genotype and no interaction between the two
(figure 5.1B). In both tasks, across all age groups, some animals failed to engage with the
task for long enough (i.e. did not spend more than 15 seconds exploring) and so were
excluded from the analysis. In the old cohort, APOE4 mice were unable to be statistically
analysed due to a small sample size (post-exclusion) in both tasks, and similarly, data from
APOE3 animals could not be analysed in the spatial object recognition task. Although
this may suggest that the animals were less engaged in the task at this time point, it’s
important to be mindful of the fact the the cohorts were small to begin with (n=3-4
animals per genotype). Larger sample sizes would be required to determine if a reduction
in task engagement is a feature of age or not. Using the data available, it appears that
animals at these age points do not display any cognitive deficits. Using a measure of
locomotion (as described in section 2.6), the activity of the mice was measured. Older
mice were less active than younger mice, but there was no interaction of age with genotype,
nor a difference between genotypes (figure 5.1C). In general, these results suggest there
were no genotype dependent effects on cognitive performance, however the small sample
sizes (post-exclusion) in the old cohort of mice means that larger group sizes would be
required in order to be certain that this finding extended into mice aged 12-13 months.
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Figure 5.1: Effect of ApoE on spatial and short term memory A. Novel object recognition
task: Discrimination ratio of amount of time spent with novel object:familiar object in young,
middle aged and old mice. B. Spatial object recognition task: Discrimination ratio of amount
of time spent in novel location:familiar location in young and middle aged mice. C. Locomotion
measure in young, middle aged and old mice. Purple bars represent APOE3 and black bars
represent APOE4. Circles represent individual animal averages and error bars represent SEM. For
detailed statistical outputs see table A.15
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5.4.2 Effect of ApoE4 and Age on resting state neuronal activity
In order to assess baseline energy demands in these mice over time, neuronal activity at
rest and in the dark was recorded, however due to time constraints only data for young
and middle aged groups were collected. The number of peaks per minute (PPM) was
calculated and no genotype or age effect was observed (figure 5.2A). The correlation of
firing was not affected by age or genotype under resting conditions (figure 5.2B) and
finally, the size of the peaks did not differ with genotype or age (figure 5.2C). As well
as averaging data across animals as in figure 5.2, it was also averaged across all cells
(figure B.3). When averaging using this method there was an effect of age on the number
of PPM as well as on the size of the peaks. Interestingly, middle aged animals displayed
higher numbers of PPM but with lower magnitudes than young animals. However, as
with animal averages, there was no effect of genotype.
In conclusion, when considering animal averages, age and genotype do not appear to
interact at these age points to modulate resting neuronal activity, and so the neuronal
characteristics and therefore presumably energy demand, in the absence of a visual
stimulation, is likely be similar across all animals.
Figure 5.2: Resting state neuronal activity A. Peaks per minute. B. Cell correlation averaged
per animal. C. Average ∆F/F of peaks. Purple bars represent APOE3 and black bars represent
APOE4. Circles represent individual animal averages and error bars represent SEM. For detailed
statistical outputs see table A.16
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5.4.3 Effect of ApoE4 and Age on resting state haemodynamic para-
meters
In order to assess the tissue energy delivery in APOE3 and APOE4 mice, and how this
was modulated by age, various parameters were investigated at both an individual vessel
level and at a more global level across the region. Resting pial and capillary diameters
were measured across all age points and there was no effect of age or genotype observed
(figures 5.3A, B), although the data shows a trend towards reduced pial diameters in
old APOE4 animals. Resting RBCV was measured across all three age points and it
was found that the average RBCV remained similar across genotypes and age points
(figures 5.3C). Net haemodynamic measurements were then analysed to look for global
differences across age and genotype. Neither flux, SO2 or CMRO2 showed any effect
of genotype or age, suggesting that these parameters also remained stable across the
lifespan in both genotypes (figures 5.3D, E, F). Finally, the coefficient of variation was
determined, to gain a measure of temporal fluctuations in the net flux, SO2 and RBCV
measurements. There was no observed effect of age or genotype on net flux or SO2
measurements (figures 5.3G, H), but there was a significant effect of genotype in RBCV
measurements. Data suggests that RBCV CV in APOE4 vessels was not differently
affected across all three age points as there was no interaction between age and genotype,
however, post hoc multiple comparisons with Bonferroni’s correction, would suggest that
this effect was present only at middle age.
These data demonstrate that the measured parameters remained mostly preserved across
all age points, with APOE4 only resulting in an increased heterogeneity of velocity,
which could result in altered oxygen extraction from the blood to the tissue (Østergaard
et al., 2013). An interesting adjunct to these findings, would be a measure of vascular
morphology in fluorescent gel filled brain slices, as was carried out in chapter 3. Vascular
density was reduced in young APOE4 mice, however this was not reflected in the net
CBF readings, possibly because of the subtlety of the effect. So despite there being no
differences in the net haemodynamic measurements, there may be more subtle changes in
older animals that can only be detected by studying the vasculature directly.
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Figure 5.3: Resting net haemodynamic parameters A. Resting pial diameter. B. Resting
capillary diameter. C. Resting red blood cell velocity (RBCV). D. Resting net flux, E. SO2 and F.
CMRO2 measurements. G. Coefficient of variation of flux, H. SO2 and I. RBCV measurements. All
measurements were made across young, middle and old time points, in both APOE3 and APOE4
animals. Purple bars represent APOE3 and black bars represent APOE4. Circles in A-C and
I represent individual vessel averages, and in D-H, circles represent individual animal averages.
Error bars represent SEM. For detailed statistical outputs see table A.17
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In addition to the above resting state parameters, vasomotion was measured at all three
age points. A reduction in vasomotion was observed in young APOE4 animals in chapter
3 (figure 5.4A) and this pattern appeared to continue across all age points. Although
the difference between the traces did not reach significance in middle aged animals
(figure 5.4B), there was a trend towards there being a lower relative power in the 0.1-
0.2Hz and 0.2 - 0.3Hz range in APOE4 mice (p = 0.077, 0.07 respectively). In old animals,
there was significantly lower relative power in APOE4 vessels in the 0.1-0.2Hz frequency
range (figure 5.4C), and although the relative power difference in the 0.2-0.3Hz frequency
range, failed to reach statistical significance, it trended strongly towards being lower in
APOE4 animals (p = 0.06). Finally, when purely considering the relative power at 0.1Hz,
the classic vasomotion frequency, an effect of genotype was observed (figure 5.4D). The
absence of an age by genotype effect suggests that the mean relative power was greater
in APOE3 vessels across all three age points and that this effect remained stable across
this section of the lifespan. Whilst when multiple comparisons were conducted, they
suggested that differences existed in only young animals, in the absence of an age by
genotype interaction we cannot conclusively say there is a difference in effects across age
groups.
As previously mentioned vasomotion is thought to be not only a valuable indicator
of vascular health, but also important for the clearance of substances from the brain
(van Veluw et al., 2019) and possibly also for perfusion and oxygenation (Rücker et al.,
2000; Tsai and Intaglietta, 1989). These data show a consistent deficit in the oscillatory
properties of APOE4 blood vessels, suggesting that there may be deficits in the afore-
mentioned clearance, perfusion and oxygenation mechanisms at each of these age points.
The examination of these baseline parameters across age yielded similar results to those
found in chapter 3. Despite similar neuronal activity and therefore energy demands at
rest, there appeared to be some subtle vascular deficits such as an increase in RBCV CV
as well as reduced vasomotion in APOE4 mice. This suggests that there may have been
a small imbalance in energy supply and demand across all age points, although not at
sufficient levels to impact SO2 or CMRO2 measurements. Without neuronal data for old
animals it’s impossible to be certain of this conclusion in that age group. It does appear
however, that there was no robust effect of age in these animals in either the neuronal or
vascular properties at rest.
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Figure 5.4: Effect of ApoE and age on vasomotion A. Relative power spectra for all averaged
APOE3 and APOE4 pial vessels from young animals. Upper right insert corresponds with the grey
dashed box. Dashed grey lines on insert graph show the frequency bins that were compared. B.
Relative power spectra for all averaged APOE3 and APOE4 pial vessels from middle aged mice.
Upper right insert corresponds with the grey dashed box. Dashed grey lines on insert graph show
the frequency bins that were compared. C. Relative power spectra for all averaged APOE3 and
APOE4 pial vessels from old animals. Upper right insert corresponds with the grey dashed box.
Dashed grey lines on insert graph show the frequency bins that were compared. D. Average relative
power at 0.1Hz across all age points. Circles represent individual vessel averages, and error bars
represent SEM. For detailed statistical outputs see table A.18
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To better understand how energy supply and demand was balanced across the three age
points, neurovascular activity in response to visual stimulation was assessed.
5.4.4 Effect of ApoE4 and Age on neuronal responses to visual stimu-
lation
When the neuronal response magnitude was compared across young and middle aged
animals, there was a consistent pattern of increased response sizes to visual stimulation in
APOE4 mice. This was observed when all cells were taken into account (figure 5.5A) and
when only responsive cells were considered (figure 5.5C). Although the genotype effect was
not statistically significant when all cells were averaged per animal (figure 5.5A), it almost
reached statistical significance with p = 0.055. When considering responsive cells only,
there was no interaction between age and genotype suggesting that the two age groups
were not differently affected. However, when multiple comparisons were made with a
Bonferroni correction, only the middle aged response size was significantly larger.
There was no observed difference in the response frequency in APOE3 and APOE4 animals
(figures 5.5 B). The number of peaks per minute of responsive cells was calculated during
visual stimulation and compared across genotypes and age points. Although there was no
effect of genotype, there was a robust effect of age (figure 5.5D). As animals got older,
the number of peaks during the stimulation appeared to reduce, although the magnitude
of these events remained the same, as seen in figure 5.5C. As with all neuronal data, in
addition to averaging by animal, data was also averaged across all cells (figure B.4) where
the same effects were observed.
These data suggest that the overall energy demand was likely slightly lower at middle age
when compared with young age, but that this was not genotype dependent and energy
demand continued to be higher in APOE4 mice at both age points.
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Figure 5.5: Neuronal responses to visual stimulation A. Top panels show average ∆F/F
traces across all cells, in response to visual stimulation in young and middle aged mice, averaged per
animal. Bottom panel shows AUC measurements for each ∆F/F trace during visual stimulation,
averaged per animal. B. Response frequency of cells to visual stimulation, averaged per animal
at both young and middle age points. C. Top panels show average ∆F/F traces across responsive
cells only, in response to visual stimulation in young and middle aged mice, averaged per animal.
Bottom panel shows AUC measurements for each responsive ∆F/F trace during visual stimulation,
averaged per animal. D. Number of peaks per minute for each cell during visual stimulation,
averaged per animal. Grey boxes represent visual stimulation. Circles represent individual animal
averages, and error bars represent SEM. For detailed statistical outputs see table A.19
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5.4.5 Vascular responses to visual stimulation
In order to assess how energy delivery was modulated by age, the vascular responses to
visual stimulation were measured at the pia and in the capillary bed. Like in the previous
chapter, vessel response frequency was measured across all age points, considering all
vessels, as well as only those with greater than 10 contributing trials. Some vessels had
only a small number of contributing trials, meaning only very low or very high response
frequencies were possible. To eliminate this effect, subgroups containing only vessels with
greater than 10 contributing trials were analysed separately. The response frequency
across age points painted a mixed picture. In chapter 4 there was a consistent trend
showing a reduction in the responsiveness of APOE4 vessels across all diameter and RBCV
measurements, however this did not continue across the age points. Pial responsiveness
did not show any effect of genotype when considering all vessels (figure 5.6A) or when
considering only those with greater than 10 trials (figure 5.6B). However there was an
effect of age when all vessels were considered, where old animals appeared to be more
responsive than young or middle aged animals. Capillary diameter responsiveness, which
was decreased in young APOE4 animals in vessels with more than 10 trials, did not display
this patten across all age points. There was no effect of genotype on either data set
(figure 5.6C, D), however when all vessels were considered there was again an effect of age,
where old APOE4 animals were most responsive (figure 5.6C). This effect was lost when
only vessels that had greater than 10 contributing trials were considered (figure 5.6D).
RBC velocity responsiveness also did not continue with the effect observed at young age,
where the RBC velocity increased less reliably in response to visual stimulation in APOE4
animals. In fact, there was again, no effect of genotype in either analysis but there was
an effect of age where old animals appeared to be more responsive (figure 5.6E). Too
few vessels had greater than 10 contributing trials at the old age point for statistical
comparisons to be made (figure 5.6F).
Overall these data do not paint a clear picture, however the reduced responsiveness that
was observed at a young age was not robust across all age points, suggesting that this may
be only a feature that presents in young animals. The apparent increase in responsiveness
in old animals was not present when the threshold of a minimum of 10 trials was applied,
so likely appeared as a result of vessels with only few contributing trials.
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Figure 5.6: Vascular response frequency A. Pial vessels response frequency to visual stimula-
tion, all vessles. B. Response frequency of pial vessels with greater than 10 trials. C. Capillary
diameter response frequency to visual stimulation, all vessels. D. Response frequency of capillary
diameters with greater than 10 trials. E. Capillary RBCV response frequency to visual stimulation,
all vessels. F. Capillary RBCV response frequency in vessels with greater than 10 trials. Circles
represent individual vessel averages, and error bars represent SEM. For detailed statistical outputs
see table A.20.
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The response magnitudes were then compared to determine if there was an effect of gen-
otype or age on response size in these older animals. As with chapter 4, all trials per
vessel were initially analysed (figure 5.7 left panel), then responsive trials only (figure 5.7
right panel). Vessel averages for responsive trials only, better reflect the response mag-
nitude as averaging all trials together confounds response rate with response size. Pial
response sizes showed an effect of age in both analyses (figures 5.7A, B), where the re-
sponse sizes appeared to be smaller in middle aged animals, however there was no effect of
genotype across any age points. Capillary diameters showed a slightly different pattern,
where there was no effect of age or genotype when all trials were analysed (figure 5.7C),
however when only responsive trials were taken into consideration, there was a genotype
effect (figure 5.7D). This appeared to be driven by an increased response size in APOE4
animals at old age, this was confirmed with a multifactorial ANOVA split by age (middle
age: F = 1.493, p = 0.227, old age: F= 10.1, p = 0.002). Finally, RBC velocity displayed
similar results, with no effects present when considering all trials (figure 5.7E), but when
looking at responsive trials only, there was an effect of age where, again, middle aged
animals appeared to have smaller response sizes (figure 5.7F).
These results, alongside the response frequency data in figure 5.6, cast some confusion
over the idea that blood vessels were less responsive in APOE4 animals and that this may
have been expected to deteriorate further with age, or that the magnitude of responses
may decrease with age. It still remains however, vascular responses did not increase in
response frequency or size, in concert with increased neuronal demand at either the young
or middle age time point. Capillary diameter responses increased in old APOE4 animals,
suggesting some degree of recovery from the subtle deficits observed in younger animals.
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Figure 5.7: Vascular responses to visual stimulation A. Top panels show average pial vessel
diameter traces in response to visual stimulation in young, middle aged and old animals. Bottom
panel shows each vessel AUC during visual stimulation. B. Top panels show average pial vessel
diameter traces of responsive trials only during visual stimulation in young, middle aged and old
animals. Bottom panel shows the AUC of the vessel average of responsive trials only during
visual stimulation. C. Top panels show average capillary diameter traces in response to visual
stimulation in young, middle aged and old animals. Bottom panel shows each vessels AUC during
visual stimulation. D. Top panels show average capillary diameter traces of responsive trials only
during visual stimulation in young, middle aged and old animals. Bottom panel shows the AUC of
the vessel average of responsive trials only during visual stimulation. E. Top panels show average
capillary RBC velocity traces in response to visual stimulation in young, middle aged and old
animals. Bottom panel shows each vessel AUC during visual stimulation. F. Top panels show
average RBC velocity traces of responsive trials only during visual stimulation in young, middle
aged and old animals. Bottom panel shows the AUC of the vessel average of responsive trials only
during visual stimulation. Grey rectangles represent visual stimulation. Circles represent individual
vessel averages, and error bars represent SEM. For detailed statistical outputs see table A.21.
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5.4.6 Net haemodynamic responses to visual stimulation
In order to assess the haemodynamics across the entire region, net measurements were
taken in response to visual stimulation across all three age points. As before, measure-
ments were taken for flux, total haemoglobin (HbT), oxygenated haemoglobin (HbO),
deoxygenated haemoglobin (HbD), oxygen saturation (SO2) and cerebral metabolic rate
of oxygen consumption (CMRO2), which is indicative of net neuronal energy use. Across
all parameters there was no effect of genotype, although as discussed in chapter 4, there
appeared to be small genotype differences in some of these parameters at young age
(figure 5.8). In HbT, HbO and SO2 AUC measurements, there was an effect of age which
appeared to be driven primarily by increases in the AUC of old animals (figure 5.8B, C,
E). This was an interesting finding, and contrary to what might be expected from existing
literature. It is important to remember however, that the group sizes were much smaller
in older animals, and so were strongly influenced by outliers, it would be pertinent to
increase the group sizes for these measurements in the future, to determine if these results
are reproducible.
Net haemodynamic responses to visual stimulation Figure on following page. A.
Top panels show average flux responses to visual stimulation in young, middle aged and
old animals. Bottom panel shows AUC for the flux responses during visual stimulation
shown in the top panel. B. Top panels show average HbT responses to visual stimulation
in young, middle aged and old animals. Bottom panel shows AUC for the HbT responses
during visual stimulation shown in the top panel. C. Top panels show average HbO
responses to visual stimulation in young, middle aged and old animals. Bottom panel
shows AUC for the HbO responses during visual stimulation, shown in the top panel. D.
Top panels show average HbD responses to visual stimulation in young, middle aged and
old animals. Bottom panel shows AUC for the HbD responses during visual stimulation,
shown in the top panel. E. Top panels show average SO2 responses to visual stimulation
in young, middle aged and old animals. Bottom panel shows AUC for the SO2 responses
during visual stimulation shown in the top panel. F. Top panels show average CMRO2
responses to visual stimulation in young, middle aged and old animals. Bottom panel
shows AUC for the CMRO2 responses during visual stimulation, shown in the top panel.
Circles represent individual animal averages, and error bars represent SEM. For detailed
statistical outputs see table A.22.
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5.5.1 Results Summary and Interpretation
APOE4 animals do not display behavioural deficits at any of the examined age
points
These animals were examined for impairments in spatial and short term memory and
no deficits were detected in APOE4 animals at either the young or middle age point.
Although, as aforementioned, the tests carried out are simple and a thorough cognitive
battery would be required to detect more subtle behavioural changes, these results do
suggest that the effects observed in young and middle aged time points, occur prior to
global cognitive changes. Further work is required to determine if this is also the case
with old animals.
Resting state parameters were then examined so that a baseline energy balance could be
determined. Not only is this interesting to examine in its own right, it also allows for a
greater understanding of the energy balance during the functional hyperaemia response
as it may be acting on top of an already energy deficient system. As a result of delayed
access to Th1-GCaMP6f animals (those with a genetically encoded calcium indicator in
excitatory neurons), neuronal data was only collected for young and middle aged animals.
Resting state neuronal characteristics do not differ by genotype
Across all three resting state measurements, peaks per minute, cell correlation and average
∆F/F, there was no effect of genotype or age. This suggests that at both age points, the
energy requirements of APOE3 and APOE4 animals were similar.
Resting state vascular characteristics are modulated by genotype but not age
Although many of the baseline parameters such as blood vessel diameter and net
haemodynamic parameters, remained unaffected by age and genotype, the trend towards
increased CV in APOE4 RBCV, observed at young age, continued across the other
age points and was particularly increased at middle age. As previously discussed,
mathematical modelling from the Østergaard group has suggested that such temporal
variation in the velocity of RBCs could result in a reduction in oxygen extraction from
the blood to the tissue (Østergaard et al., 2013), implying that there could be deficits in
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this mechanism in APOE4 mice, across all age points. In addition to this observation in
APOE4 mice, there was also a reduction in vasomotion in these animals, across all age
points. Together these alterations could result in basal reductions in tissue oxygenation
and perfusion, as well as a reduction in clearance.
Neuronal and vascular responses to visual stimulation were then investigated to examine
the ability of the local blood supply to increase energy delivery to active neurons. As
APOE4 animals already appeared to be operating with a deficit under resting conditions,
further alterations could enhance any energy insufficiencies.
Neuronal responses to visual stimulation are larger in APOE4 mice across age
groups
The magnitude of the neuronal response to visual stimulation was increased in middle
aged animals, as was observed in young animals. The ∆F/F of the GCaMP signal is
closely coupled with the number of spiking events (Akerboom et al., 2012) and so is a
valuable measure of neuronal activity and is therefore indicative of energy demand. Data
shows that young mice had more frequent calcium transients and so presumably also had
higher energy demands than middle aged mice. What is clear is that at this middle age
point, APOE4 mice continued to have increased response sizes compared to APOE3 mice,
suggesting that they had higher energy requirements. It would therefore be expected that
they would have an increased energy supply, either by accordingly increasing the response
frequency to visual stimulation, or alternatively, the response size.
Vascular responses to visual stimulation suggest that vascular unreliability
does not continue into older age
Although at young age there was a clear reduction in response frequency in APOE4 anim-
als, this did not continue robustly across all age points. All age points considered, there
was no effect of genotype on the vascular response frequency at the pia or capillary bed.
If all vessels were taken into account there was an observed effect of age which primarily
appeared to be driven by low response frequencies at the middle point. As well as this,
there was no observed reduction in the response magnitude in APOE4 animals at the pia
or the capillary bed. As the vessel averages for responsive trials only are more indicative
of net energy supply, these are the data that were focused on primarily. There was no
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difference in the size of responses at the pia or when considering capillary RBCV, as as-
sessed by AUC measurements, nor any obvious deterioration with age. However capillary
diameter responses to visual stimulation were increased in old APOE4 mice.
This evidence demonstrates that the deficits in young APOE4 animals, resolve somewhat
with age, although there was no significant interaction between age and genotype, pre-
sumably as the effect was very subtle even in young animals. Despite the lack of clear
vascular insufficiency at the later time points, its important to remember that APOE4
animals had a larger energy demand compared to APOE3 animals, and so in a healthy
system an increased vascular response would be expected.
5.5.2 Overall Discussion
This chapter aimed to elucidate the effect of ApoE4 on neurovascular properties and how
this interacted with age. Mice at 3-4 months, 6-7 months and 12-13 months were studied
and termed young, middle aged and old respectively. The data in this chapter confirmed
that some of the effects found at the young time point, continued into middle and older
ages, such as the reduction in vasomotion and the increase in the heterogeneity of RBC
velocity in APOE4 animals. These effects were robust and presented across all three age
points. Although there was no neuronal data for the old age group, middle aged animals
displayed the same hyperactive neuronal phenotype as young animals, suggesting that
the increased energy demand, alongside some deficits in vasomotion and RBCV existed
across age groups.
There was some degree of recovery with age in APOE4 animals, the reduction in vascular
response frequency observed in young animals was no longer present and capillary diameter
responses to stimulation were increased in old APOE4 animals. However in general, most
parameters did not change and remained the same throughout all the measured age points.
In this study I did not observe a degenerative phenotype with age and there are
several reasons why this may be the case. Firstly, it is important to consider the mouse
model used in this study. APOE-TR mice are not models of AD, and observing the effects
of ApoE4 alone and independent of the pathological hallmarks of AD is undoubtedly of
value but likely to be much milder than AD mouse models, in terms of deficits observed.
Future work should study how the observed changes in APOE4 animals might promote
or interact with Aβ and pathological tau
In addition, although three age points were selected, they were fairly close together and
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did not include a time point more representative of true old age in humans, such as
18-24 months. It is therefore possible that the middle aged and old time points actually
both translate to middle age in humans. The antagonistic pleiotropy hypothesis states
that APOE4 carriers have some cognitive benefits in early age, little or no difference at
middle age due to the recruitment of compensatory mechanisms and finally, when these
compensatory mechanisms are exhausted at old age, the deficits in APOE4 carriers are
observed (Tuminello and Han, 2011; Han and Bondi, 2008). Although the described
benefits at early ages are not observed in this study, it is possible that the inconsistent
results observed at middle and old age are as such due to the recruitment of compensatory
mechanisms and that large global deficits might not be observed until later in the mouse
lifespan.
The data in this chapter showing increased neuronal activity in middle aged APOE4
animals, without robust increases in vasodilation, support the energy mismatch theory
postulated in previous chapters to some extent. However it also demonstrates, at least in
the absence of Aβ and pathological tau, that any energy imbalance is not sufficient to
cause a progressive decline in neurovascular function.
5.5.3 Future work and limitations
In addition to the future experiments suggested throughout this chapter, there are some
additional points to consider. It is impossible to be certain that the fact the same mice
were imaged at young and middle age, whereas a separate cohort was used for old age,
did not have had an impact on results, especially as the time post surgery would be
greatest at middle age compared to the young and old age points. In order to improve
this, a longitudinal study where the same mice were imaged throughout but with an
extended recovery time could be considered. Although this would also be accompanied
with problems arising from long term implantation of the cranial window, such as ill
health and bone regrowth. Alternatively, three separate cohorts could be used for each
age point, meaning they would be imaged under identical conditions, although improved
recovery in young animals cannot be ruled out.
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5.5.4 Conclusion
Although the data in this chapter did not display the degenerative phenotype that might
be expected as these animals age, it provided some interesting insights into how the neur-
ovascular properties in this mouse model change over time. The disruptions to basal
energy supply initially observed in young animals, namely the reduced vasomotion and
increased RBCV CV, continued into middle and old age points. Conversely, the reduced
reliability of the vascular response observed in young animals was not seen in older anim-
als, suggesting that vascular function was somewhat improved at these later time points.
Nevertheless, the increase in neuronal energy demand in APOE4 animals was observed
in middle aged animals, without a corresponding increase in energy supply, so it is likely
that the proposed energy deficit observed in young animals might continue until at least
the middle time points. Further experiments would be required to determine if this was





This body of work sought to determine the effect of ApoE4 and age on the neurovascu-
lature in the visual cortex. We found subtle, yet robust changes in young APOE4 animals
that we speculate could be one of the early triggers in AD pathogenesis in humans. These
findings included deficits in APOE4 animals across multiple vascular elements, including
the microvascular density, vasomotion, baseline RBCV heterogeneity, as well as in the
reliability of the blood supply increase in response to neuronal activity. These vascular
deficits were accompanied by an enhanced neuronal response to visual stimulation in
APOE4 animals, where the response magnitude was larger.
These results point towards an energy mismatch in APOE4 animals, where the hy-
perexcitable neuronal phenotype would presumably result in a larger energy demand
during visual stimulation and in order to match this increased demand with adequate
blood supply and therefore adequate energy delivery, an increase in response frequency or
response size would be expected. However this was not observed, on the contrary, blood
vessel diameters and RBC velocity increased less reliably in APOE4 animals, compared
to APOE3, and the response magnitude was comparable across genotypes at both the pia
and capillary bed. Could this mismatch be the first step in a chain of events that results
in a suboptimal energy supply to APOE4 neurons, eventually resulting in hypoxia and
AD pathology (see figure 6.1)?
It is probable that this imbalance is not resulting in harmful effects in the young
APOE4 brain, considering the resting SO2 and behavioural measurements were not
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different between genotypes. Perhaps this is as a result of the “buffer” built into the
functional hyperaemia response, described previously as “watering the entire garden for
the sake of one thirsty flower” (Malonek and Grinvald, 1996). Interesting to note is
previous work from our group, comparing neurovascular function in the visual cortex
and the hippocampus which shows that the hippocampus has less of a buffer (Shaw
et al., 2019), and so might explain its vulnerability to hypoxia (Michaelis, 2012) and
in Alzheimer’s Disease. An interesting research avenue would be an investigation into
neurovascular coupling in the CA1 region of APOE4 mice to determine if the changes
observed in the cortex are present in the hippocampus, and if there are any harmful
implications as a result.
Figure 6.1: Energy mismatch hypothesis of Alzheimer’s Disease. APOE4 carriers have
an increased energy demand during stimulation, whilst having a less reliable blood supply. This
could result in an energy imbalance which, over time could result in a chronic hypoxia in the brain.
Hypoxia has been shown to play a role in neuronal damage as well as the facilitation of Aβ and
tau accumulation. Aβ and tau can further diminish the ability of the brain to supply energy in
response to synaptic activity, as well as contribute to neuronal death. Overtime this cycle could
lead to the cognitive decline observed in Alzheimer’s Disease
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Although this study presents convincing evidence for a subtle yet robust alteration to
neurovascular function in APOE4 animals, focusing on the largely preserved vascular
function across different age points, offers an interesting perspective. As discussed, we
found many vascular parameters unchanged in APOE4 animals, including neurovascular
coupling response sizes, pericyte number, pial diameters, red blood cell velocity, net
resting blood flow and net resting levels of SO2. As some of these findings are contrary to
previous work (Bell et al., 2012; Koizumi et al., 2018), it emphasises the inconsistencies
that can arise between research groups, possibly as a result of differences in experimental
preparation, therefore highlighting the importance of detailed methods information when
reporting experimental outcomes.
These data, showing preserved function across many parameters, are testament to
APOE4 being a risk factor for AD, rather than a causative factor. My data suggests that
in the absence of additional factors, the effect of ApoE4 on the vasculature is present
but mild, and perhaps relies on the compounding effects of these additional factors to
elicit the more severe vascular impairment often seen in APOE4 carriers (Zlokovic, 2013).
Perhaps the strictly controlled environment used in animal studies enhances this effect
as human subjects are exposed to a more heterogeneous combination of pathological
events that could potentially exacerbate vascular effects of ApoE4. Such factors could
be any or several of : increased age, inflammation, traumatic injury, cardiovascular risk
factors or the presence of Aβ and tau. Indeed, research from other groups shows there
to be enhanced pathophysiology at the intersection between ApoE4 and features such
as age (Bell et al., 2012), hypertension (Bender and Raz, 2012), traumatic head injury
(Mayeux et al., 1995) and hyperphosphorylated tau (Shi et al., 2017), to name but a
few. Interestingly, Montagne et al. (2020), showed BBB leakage in APOE4 carriers
to be independent of vascular risk factors and the accumulation of Aβ and tau. This
suggests that, alongside the findings in this study, loss of BBB integrity may be a key
characteristic of ApoE4 pathophysiology that does not rely on the compounding effect of
the aforementioned risks or pathologies.
My data show that vasomotion, neuronal responses to stimulation and RBCV heterogen-
eity are different in APOE4 carriers and this is stable across the section of the lifespan
investigated in this study (in the absence of interacting factors). This is interesting both
because it suggests additional factors/events are needed to push the functioning system
into a pathological state and because these differences may well be one of the reasons
why APOE4 carriers are more severely affected by such events. Therefore, studying how
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vasomotion, neuronal responses to stimulation and RBCV heterogeneity are differentially
affected by factors or events such as traumatic injury, inflammation, even older age or
Aβ accumulation, will be informative about whether these long-standing differences do
indeed mediate some of the increased risk of disease in APOE4 carriers.
This work has raised many important questions that should be answered in future studies,
as discussed in each experimental chapter. In addition to the aforementioned experiments
determining the effects of ApoE4 in combination with other, potentially exacerbating
factors, these could include experiments to study the downstream effects of the proposed
energy mismatch, such as tissue oxygenation, or of reduced vasomotion, such as clearance.
Another interesting avenue would be to investigate the mechanism(s) underlying the
effects observed in APOE4 mice and thus aid in the identification of a therapeutic target
aiming reduce these observed functional differences.
In conclusion, it is hoped that this thesis can provide some valuable information
to the field and will continue to be built upon in future studies. The more we further our
understanding of the role of ApoE4 in the Alzheimer’s disease process, particularly in the
pre-clinical phase, the closer we come to identifying therapeutic targets and developing
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Table A.9: Statistical outputs for figure 4.2 G = Genotype, CT = cell type, G*CT = geno-
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Figure B.1: Neuronal activity during rest. Cell Average A. Number of peaks per minute
during rest. B. Average correlation of firing per field of view (FOV). C. Average ∆F/F of peaks
during rest. Circles represent FOV and violin plots show data from all cells. Error bars represent
SEM. For detailed statistical output see table A.23.
187
Figure B.2: Neuronal activity during visual stimulation. Cell Average A. Average ∆F/F
traces of all cells in responsive to visual stimulation. B. AUC measurements for cell averages shown
in A. C. Average ∆F/F trace of all responsive cells. D. Area under curve measurements for the
responsive cells shown in C. E. Response frequency of cells in ApoE3 and ApoE4 animals. F. PPM
values for all responsive ApoE3 and ApoE4 cells. G. The distribution of cell types in ApoE3 and
ApoE4 animals. Grey rectangles represent the onset and offset of visual stimulation. Error bars
represent SEM. For detailed statistical output see table A.24
188
Figure B.3: Effect of age and APOE on neuronal activity during rest. Cell average. A.
Number of peaks per minute during rest. B. Average correlation of firing per field of view (FOV).
C. Average ∆F/F of peaks during rest. Circles represent FOV and violin plots show data from all
cells. Error bars represent SEM. For detailed statistical output see table A.25
189
Figure B.4: Effect of age and ApoE on neuronal responses to visual stimulation. A. Top
panels show average ∆F/F traces across all cells, in response to visual stimulation in young and
middle aged mice, averaged per cell. Bottom panel shows AUC measurements for each cells ∆F/F
trace during visual stimulation. B. Response frequency of cells to visual stimulation in both young
and middle aged animals. R = responsive, NR = non-responsive. C. Top panels show average
∆F/F traces across responsive cells only, in response to visual stimulation in young and middle
aged mice, averaged per cell. Bottom panel shows AUC measurements for each responsive cells
∆F/F trace during visual stimulation. D. Number of peaks per minute for each cell during visual
stimulation. Error bars represent SEM and violin plots show data from all cells. For detailed
statistical output see table A.26
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Figure B.5: The effect of secondary genotype on response size and frequency. A. Re-
sponsive pial vessel AUC, split by secondary genotype for ApoE3 and ApoE4 mice. B. Pial vessel
response rate, split by secondary genotype for ApoE3 and ApoE4 mice. C. Responsive capillary
RBCV AUC, split by secondary genotype for ApoE3 and ApoE4 mice. D. RBCV response rate,
split by secondary genotype for ApoE3 and ApoE4 mice. E. Responsive capillary AUC, split by
secondary genotype for ApoE3 and ApoE4 mice. F. Capillary response rate, split by secondary
genotype for ApoE3 and ApoE4 mice. Individual points represent vessels, error bars represent
SEM. For detailed statistical output see table A.27.
